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            Brain wiring is critical for normal brain function, and brain connection defects 
have been described in many neurodevelopmental disorders. Accurate central nervous 
system connectivity relies on precise axon navigation. The cellular and molecular 
mechanisms governing axon guidance during development are important but not well 
understood.  
            In this dissertation, I utilize zebrafish, a powerful vertebrate model in 
developmental and genetic studies, to determine the molecular mechanisms regulating 
axon guidance in vivo. We specifically determine the role of the two molecules FoxP2 
and serotonin (5-HT) in axon guidance. We demonstrate that FoxP2, a forkhead-domain 
transcription factor, is not required for axon guidance, but it reduces the expression levels 
of a synaptic protein Cntnap2. We also establish that 5-HT and its receptor Htr2a are 
important for axon guidance. The regulation of 5-HT on axon guidance is mediated by 
the tyrosine kinase Ephrinb2a. Moreover, we discover that axon guidance defects induced 
by environmental hypoxia can be rescued by serotonin reuptake inhibitor fluoxetine. I 
have also developed and implemented a PCR-based high resolution melting analysis 
(HRMA) for large-scale genotype screening and characterization of genes involved in 
axon development. Taken together, this work identifies a novel mechanism involved in 
central nervous system connectivity, and indicates raphe 5-HT neurons act as a sensor to 
alterations in the developmental environment. 
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            Neurodevelopmental disorders are a group of conditions characterized by 
impairments in central nervous system (CNS) development. These disorders typically 
manifest in childhood or adolescence. Neurodevelopmental disorders include, but are not 
limited to, autism spectrum disorders, intellectual disability, attention deficit 
hyperactivity disorder (ADHD), and cerebral palsy. In many patients with 
neurodevelopmental disorders, disruption of brain connectivity has been observed (van 
Ewijk et al., 2012; Minshew and Williams, 2007; Sundaram et al., 2014; Thomas et al., 
2005).  
Intact brain connectivity depends on accurate axon navigation, which requires the 
appropriate interaction between axon guidance molecules and their receptors. Therefore, 
disrupted signaling induced by genetic or environmental factors during axon development 
may have devasting results in early brain circuit formation and later behavior. Revealing 
the molecular mechanisms underlying axon guidance will provide more insight in 
understanding and treating neurodevelopmental disorders. 
     Axon guidance is a critical developmental process by which neurons send axon 
projections to the correct targets. Growing axons have a highly specialized and dynamic 
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structure located at each axon tip called the growth cone. Receptors on the growth cone 
can sense environmental signaling or guidance cues, promoting the reorganization of the 
cytoskeleton. Each receptor acts and responds to different guidance cues. Various 
guidance molecule pairs have been discovered, including the four best-described 
“canonical” signaling pairs: Slit-Robo, Netrin-DCC/Unc5, Ephrin-Eph, and Semaphorin-
Plexin/Neuropilin (Barton et al., 2004; Bashaw and Klein, 2010, Figure 1.1). Appropriate 
interaction between axon guidance molecules and receptors ensures accurate axon 
pathfinding during development. Therefore, it is critical to understand the regulation of 
axon guidance molecules and their receptors by endogenous and exogenous stimuli. 
            Though many studies have focused on molecular signaling in early development, 
many questions still remain. These questions include how the mRNA or protein levels of 
axon guidance receptors are regulated by upstream signaling during the guidance of 
axons to the correct targets. In this dissertation, two potential regulators, FoxP2 and 
serotonin (5-HT), are discussed. I follow the standard nomenclature used to refer to the 
protein in different species: FOXP2 in human, Foxp2 in mouse, and FoxP2 in other 
chordates. Gene names are in italic (Vernes et al., 2011). 
 
FOXP2 in language and brain development 
            FOXP2, a forkhead-box transcription factor, is well known for its role in language 
development. It was originally identified in a family with a severe speech and language 
disorder, and has subsequently been identified in other patients with language defects as 
well (Feuk et al., 2006; Lai et al., 2001; Lennon et al., 2007; MacDermot et al., 2005; 
Shriberg et al., 2006; Watkins et al., 2002a; Zeesman et al., 2006). Further studies  
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showed that haploinsufficiency for FOXP2 in humans leads to defects in grammatical 
language construction, as well as in the sequencing of orofacial movements required for 
speech articulation (Vargha-Khadem et al., 2005).  
Individuals with language impairments from human FOXP2 mutant pedigrees 
have altered neural activity in Broca’s area and abnormal grey matter in the basal ganglia 
and prefrontal cortex, as shown by functional and volumetric magnetic resonance 
imaging (MRI) (Belton et al., 2003; Liégeois et al., 2003; Watkins et al., 2002b). 
However, how FOXP2 deficiency contributes to the brain abnormalities is not well 
understood. 
            Evidence from other species also indicates that FOXP2 plays an important role in 
brain development. In mice, Foxp2 heterozygotes have impaired motor learning (Groszer 
et al., 2008), while homozygotes have a smaller cerebellum (Groszer et al., 2008), 
disorganization of the Purkinje cell layer in the cerebellum, and reduced ultrasonic 
vocalization (Shu et al., 2005). In songbirds, FoxP2 is required for normal vocal learning 
or imitation of tutor songs during a juvenile sensitive period (Haesler et al., 2004; 
Teramitsu et al., 2004). 
In addition, studies indicate that Foxp2 is necessary for intact synaptic function: 
Foxp2 nulls have impaired synaptic plasticity and knock in of the human version of 
FOXP2 in mice increases long-term depression in medium spiny neurons (Enard et al., 
2009; Groszer et al., 2008). This evidence supports a role for Foxp2 in the development 
of brain connectivity. Nevertheless, the underlying developmental process that FOXP2 is 
involved in is not well characterized.  
            A few studies have suggested that FOXP2 may contribute to axon development. 
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In vitro chromatin immunoprecipitation (ChIP) showed that FOXP2 regulates multiple 
molecules involved in axon guidance, including EPHA2 and SEMA3B (Spiteri et al., 
2007; Vernes et al., 2007). Cell culture shows that FOXP2 is necessary for axon 
outgrowth, consistent with the finding that FOXP2 can regulate the gene networks 
involved in controlling the length and branching of neuronal projections (Vernes et al., 
2011). However, little information is available about the role of FOXP2 in axon 
pathfinding in vivo. In Chapter 3, I examine whether axon guidance is disrupted in 
zebrafish FoxP2 mutants (Figure 1.2). 
As a transcription factor, FOXP2 targets and regulates many downstream 
transcripts. Genome-wide chromatin immunoprecipitation (ChIP) has identified hundreds 
of DNA promoters bound by FOXP2 (Vernes et al., 2011), many of which function in 
early brain development. This study also shows that contactin-associated protein-like 2 
(CNTNAP2), a member of the neurexin family, is a target of FOXP2 (Vernes et al., 2011).  
Genome-wide analysis has linked the gene CNTNAP2 to both specific language 
impairment and autism (Alarcón et al., 2008; Arking et al., 2008; Peñagarikano et al., 
2011; Whitehouse et al., 2011). Genetic variation in CNTNAP2 is associated with altered 
CNS connectivity (Scott-Van Zeeland et al., 2010). During brain development, 
CNTNAP2 is highly enriched in the frontal and anterior lobes, striatum, dorsal thalamus, 
and Broca’s area (Rodenas-Cuadrado et al., 2014), consistent with its role in language 
development and cognitive function. The protein product of CNTNAP2 facilitates cell-
cell interaction in the nervous system (Rodenas-Cuadrado et al., 2014). Therefore, I 
hypothesized that misregulation of CNTNAP2 by FOXP2 may, at least partially, account 










Figure 1.2. Development of TCPT axons and the molecular signaling tested. A). TCPT 
commissure axons starting to cross the midline. B) Diagram of the major hypothesis 











FOXP2 mutations. However, whether the FOXP2/CNTNAP2 signaling pathway exists in 
vivo has not been clarified. In Chapter 3, I determine the role of FoxP2 in axon 
development and further test whether the FoxP2/CNTNAP2 signaling pathway is 
conserved in zebrafish (Figure 1.2). 
            The FOXP2 gene is highly conserved in vertebrates. Mouse and human FOXP2 
orthologs only differ by three amino acids. The zebrafish FoxP2 protein has 86% 
homology with the human protein. The FoxP2 expression pattern in the CNS is also 
conserved in vertebrates, as shown in mice, songbirds, and humans (Bonkowsky and 
Chien, 2005; Ferland et al., 2003; Haesler et al., 2004; Lai et al., 2003; Takahashi et al., 
2003). Therefore, dissecting the role of FoxP2 in zebrafish development may provide 
insight into the mechanism by which FOXP2 functions in the development of human 
brain architecture.  
 
5-HT and brain development 
            In the adult CNS, the neurotransmitter 5-HT acts as a molecular modulator of the 
strength of synaptic signals (Lesch and Waider, 2012). Many studies have addressed the 
role of 5-HT in adult physiological processes and behavior including, but not limited to, 
sleeping, appetite, emotion, and memory consolidation (Gingrich et al., 2003). Therefore, 
perturbation of the serotonergic system by drugs or adverse environment can lead to 
deficits in biological physiology and behavior. 
Intriguingly, accumulated evidence shows a nonclassical role for 5-HT during 
development. 5-HT and its receptors have been detected during vertebrate CNS 
development, prior to the development of behaviors requiring 5-HT (Gaspar et al., 2003). 
!!
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Loss of 5-HT neurons or other components of 5-HT signaling in early development leads 
to broad CNS abnormalities with a wide range of behavioral phenotypes (van Kleef et al., 
2012). A genetic model that temporally regulates HTR1A (5-HT receptor 1A) 
demonstrates that the serotonergic system acts during development, not the adult stage, to 
establish normal anxiety-like behavior (Gross et al., 2002).  
Work in rodent models provides more evidence supporting a role for 5-HT in 
early brain development. Impaired barrel cortex is observed in serotonin transporter (5-
HTT) knockout mice (Persico et al., 2001); the number of synapses in the visual cortex is 
decreased followed by drug-induced 5-HT depletion (Matsukawa et al., 2003); neurons in 
the somatosensory cortex display a reduced dendritic arborization when 5-HT is depleted 
(Vitalis et al., 2007); either exogenous 5-HT or a 5-HTR6 (serotonin receptor 6) agonist 
can block embryonic cortical interneuron migration (Riccio et al., 2009). However, these 
studies did not exclude the possibility that these defects observed following serotonergic 
signaling disruption may derive from the secondary effects caused by perturbations in 
normal brain development.  
A potential role for 5-HT in axon pathfinding has been observed, as well as its 
role in axon branching, synapse formation, dendrite arborization, and interneuron 
migration. In mouse thalamocortical neuron explants, application of 5-HT caused a 
repulsive response to netrin-1 and overexpression of the 5-HT receptor htr1b/1d caused 
dorso-ventral shifting of the axon tracts (Bonnin et al., 2007). In rat raphe neuron 
explants, knockdown of the 5-HT transporter led to altered fasciculation and projections 
of axons (Witteveen et al., 2013). However, evidence for a cell-autonomous role of 5-HT 
receptors in axon pathfinding is lacking. Moreover, the direct mechanism by which 5-HT 
!!
9 
regulates axon guidance in vivo is not well understood. Axon guidance receptors are 
critical in recognizing guidance cues leading to the possibility that 5-HT could regulate 
guidance receptors and further contribute to the development of axon connectivity. In 
Chapter 4, I test the role of 5-HT in axon guidance and investigate the potential 
mechanism involved in the process. 
 
Ephrin/eph signaling in axon guidance 
            As mentioned in the overview, ephrin/eph signaling is one of the four best-
described “canonical” pathways involved in axon guidance. Ephrins are 
glycosylphosphatdylinostol (GPI) anchored transmembrane proteins. They are known to 
interact with EphA or EphB receptors, the largest receptor-tyrosine kinases (RTK) 
families. When acting as ligands, ephrins induce an intracellular signaling cascade in eph-
expressing cells (Bashaw and Klein, 2010). This is known as “forward signaling”. As 
membrane-bound proteins (Pasquale, 2008), ephrins can also induce “reverse signaling”, 
in which signals transfer from ephs to ephrins, activating the downstream signaling in 
ephrin-expressing cells. As opposed to a variety of other axon guidance cues/receptors, 
signal transduction between ephrins and ephs requires cell-cell interaction. Therefore, one 
feature of ephrin/eph signals is that interactions occur only at adjacent cells (Bashaw and 
Klein, 2010). 
            Several studies have demonstrated that ephrinBs and their receptors play an 
important role in regulating midline axon crossing (Cramer et al., 2006; Frisén et al., 
1999; Henkemeyer et al., 1996; Kullander et al., 2001; Nakagawa et al., 2000). For 
example, ephrinB expressed at the midline optic chiasm repels ipsilateral retinal axons 
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crossing the midline (Nakagawa et al., 2000) and ephB2 expressed in the brainstem 
prohibits axons crossing back over the midline (Cramer et al., 2006). Consistent with a 
critical role of ephrinB2 in axon guidance, misregulated ephrinB in early development 
leads to axon guidance disruptions. Our lab observed that increased ephrinB2a 
contributes to midline axon guidance defects under hypoxic conditions (Stevenson et al., 
2012). Interestingly, this is mediated by ephrins/ephs “reverse signaling” (Stevenson et 
al., 2012). 
            Based on the potential role of 5-HT in axon development (Bonnin et al., 2007; 
Witteveen et al., 2013) and the fact that ephrinB2a is expressed in TCPTc (Stevenson et 
al., 2012), I hypothesize that 5-HT regulates axon guidance through ephrinB2a. I test the 
hypothesis in Chapter 4 (Figure 1.2).  
 
5-HT as an environmental sensor 
 Neural circuitry development in the vertebrate brain is governed not only by 
genetic, but also by environmental factors. For example, during perinatal sensitive 
periods, early-life stress, nutrition, and maternal care affect brain structure and function 
(Korosi and Baram, 2009; Lucassen et al., 2013; Weinstock, 2008). However, how neural 
circuits are manipulated by environmental stimuli remains elusive.  
Studies have found that environmental stimuli including hypoxia, pH, and 
chemicals can modify the serotonergic system (Bosker et al., 1994; Davis, 1975; 
Eddahibi et al., 1999; Hickner et al., 2014; Kellum et al., 1983; Pocock and Hobert, 
2010a; Rahman and Thomas, 2009, 2014). In C. elegans, hypoxia activates an additional, 
previously unrecognized neural circuit for chemosensory perception (Pocock and Hobert, 
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2010b). Interestingly, enhanced sensory perception is mediated by 5-HT and its receptor 
ser-7. (Pocock and Hobert, 2010a). These studies suggest that 5-HT is a potential intrinsic 
modulator responsive to exogenous developmental or environmental cues (Chaouluff, 
2000).  
However, the neural circuits modified by 5-HT under hypoxia are not well 
characterized. Hypoxia is a key adverse environmental factor in early development, 
especially for premature infants with underdeveloped lungs and cardiovascular system at 
birth. Children born prematurely are more likely to suffer from neurological disorders 
(Bass et al., 2004; Barrett et al., 2007; Mathiasen et al., 2011; Raman et al., 2006). Based 
on diffusion tension imaging data, premature birth could lead to CNS connectivity 
disruption (Yeatman et al., 2009). Specific axon guidance defects have also been 
observed following hypoxia in both zebrafish and C. elegans (Stevenson et al., 2012 and 
Pocock & Hobert, 2009). However, whether 5-HT contributes to axon connectivity 
disruption in response to developmental hypoxia is still unexplored.  
            Based on the fact that hypoxia could affect the serotonergic system in vertebrates 
(Davis, 1975; Rahman and Thomas, 2009) and because of a potential role of 5-HT in 
axon development (Bonnin et al., 2007; Witteveen et al., 2013), I hypothesize that 5-HT 
contributes to axon guidance defects under hypoxia. I test this hypothesis in Chapter 4. A 
role of 5-HT in sensing exogenous stimuli and further altering neural circuits during 
development may explain neurobehavioral repertoire changes in response to parental or 
developmental exposures. 
In this dissertation, I take advantage of the ease of use of the zebrafish model and 
apply pharmacological, genetic and molecular tools, including high-resolution melting 
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analysis (HRMA), to promote our understanding of the molecular mechanisms involved 
in axon guidance. 
 
Advantages of zebrafish in developmental studies 
The zebrafish is a widely used vertebrate model in genetic and developmental 
studies due to its transparent embryos, rapid developmental process, external fertilization, 
and powerful genetic tools, including numerous mutant and easy to generate transgenic 
lines. In this dissertation, the transgenic line Tg(foxP2-enhancerA.2:egfp-caax)zc69 is 
utilized to monitor axon development in zebrafish. Tg(foxP2-enhancerA.2:egfp-caax) 
labels neurons in the telencephalon, and their axons with assistance of the membrane-
targeted motif caax.  Axons either form the anterior commissure, the diencephalic tract of 
the commissure of the posterior tuberculum (TCPTc) (Wilson et al., 1990), or 
longitudinal axons (Figure 1.3). In this dissertation, I focus on the molecular mechanisms 
involved in TCPTc development. The axons forming TCPTc extend around 24 hpf (hours 
post-fertilization), start to cross the midline at 36-48 hpf, and most axons have crossed by 
72 hpf.  
 
High-resolution melting analysis (HRMA) in genotyping 
Traditional genotyping approaches have limitations in rapid and large-scale 
screening.  PCR followed by gel electrophoresis, sometimes combined with restriction 
enzyme digestion, is time-consuming and less sensitive for small deletions or insertions. 








Figure 1.3. The axons labeled by foxP2-enhancer A.2:egfp-caax. In the dissertation, we 




PCR products is tedious and not suitable for large-scale screening.  
           HRMA, a closed-tube post-PCR analysis method, has been developed for 
screening large numbers of animals. HRMA is a rapid, sensitive, and inexpensive 
approach for genotyping. HRMA is based on thermal denaturation of double-stranded 
DNAs—each PCR amplicon has a unique dissociation (melt) characteristic. Samples can 
be discriminated based on their different nucleotides, GC content, or length, typically in 
combination with a fluorescent dye that only binds to double-stranded DNA. HRMA can 
be used to detect SNPs, mutations, and transgenes (Dahlem et al., 2012; Liew et al., 
2004; Vossen et al., 2009). Since HRMA uses low-cost reagents and is a single-step post-
PCR process, it is amenable to high-throughput screening.  
HRMA has been applied in many organisms and systems, including cell lines,!
mice, and humans (Carrillo et al. 2013; Thomsen et al. 2012; Vorkas et al. 2010). Its use 
has recently been described in zebrafish to detect mutations induced by zinc finger 
nucleases (ZFNs) or transcription activator-like effector nucleases (TALENs) (Dahlem et 
al., 2012; Xing et al., 2012).  
            Chapter 2 is a peer-reviewed paper and video discussing how to apply HRMA in 
both embryonic and adult fish to detect transgenes and mutations. This helps the 
scientific research community see exactly how this technique works. I first apply HRMA 
in fin clips of embryos prior to phenotype analysis. This is extremely useful when 
homozygotes are not viable or fertile. Though the foxP2 nulls I obtained are fertile, 
almost all were female for unidentified reasons; therefore it was necessary to intercross 
heterozygotes and genotype individual embryos by fin clip prior to analyzing their 
phenotypes. In this thesis, I applied two different strategies to generate knockout fish: 
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zinc finger nucleases (ZFNs) and the Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR). HRMA greatly facilitates genotyping multiple genetic lines or mutant 
lines, maximizing the power of mutagenesis tools. 
 
Summary 
            CNS connectivity is altered in patients with specific language impairment and in 
other neurodevelopmental disorders including autism spectrum disorders, intellectual 
disability, ADHD, and cerebral palsy (van Ewijk et al., 2012; Minshew and Williams, 
2007; Sundaram et al., 2014; Thomas et al., 2005). Connections between different brain 
regions rely on accurate axonal and synaptic development. Thus, unraveling the genetic 
pathways and neural circuitry involved in axon pathfinding, an important process for 
CNS connectivity, will facilitate understanding the pathogenic mechanisms in 
neurodevelopmental disorders. In this dissertation, I have used the zebrafish as a model, 
combined with different experimental strategies, including pharmacological, genetic and 
molecular tools to study whether FoxP2 and/or 5-HT is involved in axon pathfinding. I 
have also tested whether FoxP2 and 5-HT regulate CNTNAP2 and ephrinB2a in Chapter 
3 and Chapter 4, respectively (Figure 1.2). In Chapter 2, I have applied HRMA for large-
scale genotype screening in zebrafish, which helps facilitate the characterization of genes 
involved in axon development. Taken together, this dissertation contributes to a better 





Alarcón, M., Abrahams, B.S., Stone, J.L., Duvall, J.A., Perederiy, J. V., Bomar, J.M., 
Sebat, J., Wigler, M., Martin, C.L., Ledbetter, D.H., et al. (2008). linkage, association, 
and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. 
J. Hum. Genet. 82, 150–159. 
 
Arking, D.E., Cutler, D.J., Brune, C.W., Teslovich, T.M., West, K., Ikeda, M., Rea, A., 
Guy, M., Lin, S., Cook, E.H., et al. (2008). A common genetic variant in the neurexin 
superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 
82, 160–164. 
Barton, W.A., Himanen, J.-P., Antipenko, A., and Nikolov, D.B. (2004). Structures of 
axon guidance molecules and their neuronal receptors. Adv. Protein Chem. 68, 65–106. 
 
Bashaw, G.J., and Klein, R. (2010). Signaling from axon guidance receptors. Cold Spring 
Harb. Perspect. Biol. 2, a001941. 
 
Belton, E., Salmond, C.H., Watkins, K.E., Vargha-Khadem, F., and Gadian, D.G. (2003). 
Bilateral brain abnormalities associated with dominantly inherited verbal and orofacial 
dyspraxia. Hum. Brain Mapp. 18, 194–200. 
 
Bonkowsky, J.L., and Chien, C.-B. (2005). Molecular cloning and developmental 
expression of foxP2 in zebrafish. Dev. Dyn. 234, 740–746. 
 
Bonnin, A., Torii, M., Wang, L., Rakic, P., and Levitt, P. (2007). Serotonin modulates the 
response of embryonic thalamocortical axons to netrin-1. Nat. Neurosci. 10, 588–597. 
 
Bosker, F., Klompmakers, A., and Westenberg, H. (1994). Extracellular 5-
hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by 
nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to 
tetrodotoxin. J. Neurochem. 63, 2165–2171. 
 
Cramer, K.S., Cerretti, D.P., and Siddiqui, S.A. (2006). EphB2 regulates axonal growth at 
the midline in the developing auditory brainstem. Dev. Biol. 295, 76–89. 
 
Dahlem, T.J., Hoshijima, K., Jurynec, M.J., Gunther, D., Starker, C.G., Locke, A.S., 
Weis, A.M., Voytas, D.F., and Grunwald, D.J. (2012). Simple methods for generating 
and detecting locus-specific mutations induced with TALENs in the zebrafish genome. 
PLoS Genet. 8, e1002861. 
 
Davis, J.N. (1975). Adaptation of brain monoamine synthesis to hypoxia in the rat. J. 
Appl. Physiol. 39, 215–220. 
 
Eddahibi, S., Fabre, V., Boni, C., Martres, M.P., Raffestin, B., Hamon, M., and Adnot, S. 
(1999). Induction of Serotonin Transporter by Hypoxia in Pulmonary Vascular Smooth 
!!
17 
Muscle Cells!: Relationship With the Mitogenic Action of Serotonin. Circ. Res. 84, 329–
336. 
 
Enard, W., Gehre, S., Hammerschmidt, K., Hölter, S.M., Blass, T., Somel, M., Brückner, 
M.K., Schreiweis, C., Winter, C., Sohr, R., et al. (2009). A humanized version of Foxp2 
affects cortico-basal ganglia circuits in mice. Cell 137, 961–971. 
 
Van Ewijk, H., Heslenfeld, D.J., Zwiers, M.P., Buitelaar, J.K., and Oosterlaan, J. (2012). 
Diffusion tensor imaging in attention deficit/hyperactivity disorder: A systematic review 
and meta-analysis. Neurosci. Biobehav. Rev. 36, 1093–1106. 
 
Ferland, R.J., Cherry, T.J., Preware, P.O., Morrisey, E.E., and Walsh, C.A. (2003). 
Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature 
brain. J. Comp. Neurol. 460, 266–279. 
 
Feuk, L., Kalervo, A., Lipsanen-Nyman, M., Skaug, J., Nakabayashi, K., Finucane, B., 
Hartung, D., Innes, M., Kerem, B., Nowaczyk, M.J., et al. (2006). Absence of a 
paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am. J. Hum. Genet. 
79, 965–972. 
 
Frisén, J., Holmberg, J., and Barbacid, M. (1999). Ephrins and their Eph receptors: 
multitalented directors of embryonic development. EMBO J. 18, 5159–5165. 
 
Gaspar, P., Cases, O., and Maroteaux, L. (2003). The developmental role of serotonin: 
news from mouse molecular genetics. Nat. Rev. Neurosci. 4, 1002–1012. 
 
Gingrich, J.A., Ansorge, M.S., Merker, R., Weisstaub, N., and Zhou, M. (2003). New 
lessons from knockout mice: The role of serotonin during development and its possible 
contribution to the origins of neuropsychiatric disorders. CNS Spectr. 8, 572–577. 
 
Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, 
S., and Hen, R. (2002). Serotonin1A receptor acts during development to establish 
normal anxiety-like behaviour in the adult. Nature 416, 396–400. 
 
Groszer, M., Keays, D.A., Deacon, R.M.J., de Bono, J.P., Prasad-Mulcare, S., Gaub, S., 
Baum, M.G., French, C.A., Nicod, J., Coventry, J.A., et al. (2008). Impaired synaptic 
plasticity and motor learning in mice with a point mutation implicated in human speech 
deficits. Curr. Biol. 18, 354–362. 
 
Haesler, S., Wada, K., Nshdejan, A., Morrisey, E.E., Lints, T., Jarvis, E.D., and Scharff, 
C. (2004). FoxP2 expression in avian vocal learners and non-learners. J. Neurosci. 24, 
3164–3175. 
 
Henkemeyer, M., Orioli, D., Henderson, J.T., Saxton, T.M., Roder, J., Pawson, T., and 
Klein, R. (1996). Nuk Controls Pathfinding of Commissural Axons in the Mammalian 
Central Nervous System. Cell 86, 35–46. 
!!
18 
Hickner, S., Hussain, N., Angoa-Perez, M., Francescutti, D.M., Kuhn, D.M., and 
Mateika, J.H. (2014). Ventilatory long-term facilitation is evident after initial and 
repeated exposure to intermittent hypoxia in mice genetically depleted of brain serotonin. 
J. Appl. Physiol. 116, 240–250. 
 
Kellum, J., McCabe, M., Schneier, J., and Donowitz, M. (1983). Neural control of acid-
induced serotonin release from rabbit duodenum. Am. J. Physiol. 245, G824–G831. 
Van Kleef, E.S.B., Gaspar, P., and Bonnin, A. (2012). Insights into the complex influence 
of 5-HT signaling on thalamocortical axonal system development. Eur. J. Neurosci. 35, 
1563–1572. 
 
Korosi, A., and Baram, T.Z. (2009). The pathways from mother’s love to baby's future. 
Front. Behav. Neurosci. 3, 27. 
 
Kullander, K., Croll, S.D., Zimmer, M., Pan, L., McClain, J., Hughes, V., Zabski, S., 
DeChiara, T.M., Klein, R., Yancopoulos, G.D., et al. (2001). Ephrin-B3 is the midline 
barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral 
motor control. Genes Dev. 15, 877–888. 
 
Lai, C.S.L., Fisher, S.E., Hurst, J.A., Vargha-Khadem, F., and Monaco, A.P. (2001). A 
forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413, 
519–523. 
 
Lai, C.S.L., Gerrelli, D., Monaco, A.P., Fisher, S.E., and Copp, A.J. (2003). FOXP2 
expression during brain development coincides with adult sites of pathology in a severe 
speech and language disorder. Brain 126, 2455–2462. 
 
Lennon, P.A., Cooper, M.L., Peiffer, D.A., Gunderson, K.L., Patel, A., Peters, S., 
Cheung, S.W., and Bacino, C.A. (2007). Deletion of 7q31.1 supports involvement of 
FOXP2 in language impairment: clinical report and review. Am. J. Med. Genet. A 143A, 
791–798. 
 
Lesch, K.-P., and Waider, J. (2012). Serotonin in the modulation of neural plasticity and 
networks: implications for neurodevelopmental disorders. Neuron 76, 175–191. 
 
Liégeois, F., Baldeweg, T., Connelly, A., Gadian, D.G., Mishkin, M., and Vargha-
Khadem, F. (2003). Language fMRI abnormalities associated with FOXP2 gene 
mutation. Nat. Neurosci. 6, 1230–1237. 
 
Liew, M., Pryor, R., Palais, R., Meadows, C., Erali, M., Lyon, E., and Wittwer, C. 
(2004). Genotyping of single-nucleotide polymorphisms by high-resolution melting of 
small amplicons. Clin. Chem. 50, 1156–1164. 
 
Lucassen, P.J., Naninck, E.F.G., van Goudoever, J.B., Fitzsimons, C., Joels, M., and 
Korosi, A. (2013). Perinatal programming of adult hippocampal structure and function; 
emerging roles of stress, nutrition and epigenetics. Trends Neurosci. 36, 621–631. 
!!
19 
MacDermot, K.D., Bonora, E., Sykes, N., Coupe, A.-M., Lai, C.S.L., Vernes, S.C., 
Vargha-Khadem, F., McKenzie, F., Smith, R.L., Monaco, A.P., et al. (2005). 
Identification of FOXP2 truncation as a novel cause of developmental speech and 
language deficits. Am. J. Hum. Genet. 76, 1074–1080. 
 
Matsukawa, M., Nakadate, K., Ishihara, I., and Okado, N. (2003). Synaptic loss following 
depletion of noradrenaline and/or serotonin in the rat visual cortex: a quantitative electron 
microscopic study. Neuroscience 122, 627–635. 
 
Minshew, N.J., and Williams, D.L. (2007). The new neurobiology of autism: cortex, 
connectivity, and neuronal organization. Arch. Neurol. 64, 945–950. 
 
Nakagawa, S., Brennan, C., Johnson, K.G., Shewan, D., Harris, W.A., and Holt, C.E. 
(2000). Ephrin-B regulates the Ipsilateral routing of retinal axons at the optic chiasm. 
Neuron 25, 599–610. 
 
Pasquale, E.B. (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell 
133, 38–52. 
 
Peñagarikano, O., Abrahams, B.S., Herman, E.I., Winden, K.D., Gdalyahu, A., Dong, H., 
Sonnenblick, L.I., Gruver, R., Almajano, J., Bragin, A., et al. (2011). Absence of 
CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related 
deficits. Cell 147, 235–246. 
 
Persico, A.M., Mengual, E., Moessner, R., Hall, F.S., Revay, R.S., Sora, I., Arellano, J., 
DeFelipe, J., Gimenez-Amaya, J.M., Conciatori, M., et al. (2001). Barrel pattern 
formation requires serotonin uptake by thalamocortical afferents, and not vesicular 
monoamine release. J. Neurosci. 21, 6862–6873. 
 
Pocock, R., and Hobert, O. (2010). Hypoxia activates a latent circuit for processing 
gustatory information in C. elegans. Nat. Neurosci. 13, 610–614. 
 
Rahman, M.S., and Thomas, P. (2009). Molecular cloning, characterization and 
expression of two tryptophan hydroxylase (TPH-1 and TPH-2) genes in the 
hypothalamus of Atlantic croaker: down-regulation after chronic exposure to hypoxia. 
Neuroscience 158, 751–765. 
 
Rahman, M.S., and Thomas, P. (2014). Restoration of tryptophan hydroxylase functions 
and serotonin content in the Atlantic croaker hypothalamus by antioxidant treatment 
during hypoxic stress. Front. Neurosci. 8, 130. 
Riccio, O., Potter, G., Walzer, C., Vallet, P., Szabó, G., Vutskits, L., Kiss, J.Z., and 
Dayer, A.G. (2009). Excess of serotonin affects embryonic interneuron migration through 
activation of the serotonin receptor 6. Mol. Psychiatry 14, 280–290. 
 
Rodenas-Cuadrado, P., Ho, J., and Vernes, S.C. (2014). Shining a light on CNTNAP2: 
complex functions to complex disorders. Eur. J. Hum. Genet. 22, 171–178. 
!!
20 
Scott-Van Zeeland, A.A., Abrahams, B.S., Alvarez-Retuerto, A.I., Sonnenblick, L.I., 
Rudie, J.D., Ghahremani, D., Mumford, J.A., Poldrack, R.A., Dapretto, M., Geschwind, 
D.H., et al. (2010). Altered functional connectivity in frontal lobe circuits is associated 
with variation in the autism risk gene CNTNAP2. Sci. Transl. Med. 2, 56ra80. 
 
Shriberg, L.D., Ballard, K.J., Tomblin, J.B., Duffy, J.R., Odell, K.H., and Williams, C.A. 
(2006). Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 
translocation affecting FOXP2. J. Speech. Lang. Hear. Res. 49, 500–525. 
 
Shu, W., Cho, J.Y., Jiang, Y., Zhang, M., Weisz, D., Elder, G.A., Schmeidler, J., De 
Gasperi, R., Sosa, M.A.G., Rabidou, D., et al. (2005). Altered ultrasonic vocalization in 
mice with a disruption in the Foxp2 gene. Proc. Natl. Acad. Sci. U. S. A. 102, 9643–
9648. 
 
Spiteri, E., Konopka, G., Coppola, G., Bomar, J., Oldham, M., Ou, J., Vernes, S.C., 
Fisher, S.E., Ren, B., and Geschwind, D.H. (2007). Identification of the Transcriptional 
Targets of FOXP2, a Gene Linked to Speech and Language, in Developing Human Brain. 
Am. J. Hum. Genet. 81, 1144–1157. 
 
Stevenson, T.J., Trinh, T., Kogelschatz, C., Fujimoto, E., Lush, M.E., Piotrowski, T., 
Brimley, C.J., and Bonkowsky, J.L. (2012). Hypoxia disruption of vertebrate CNS 
pathfinding through ephrinB2 Is rescued by magnesium. PLoS Genet. 8, e1002638. 
 
Sundaram, S., Huq, A.H.M., Hsia, T., and Chugani, H. (2014). Exome sequencing and 
diffusion tensor imaging in developmental disabilities. Pediatr. Res. 75, 443–447. 
 
Takahashi, K., Liu, F.-C., Hirokawa, K., and Takahashi, H. (2003). Expression of Foxp2, 
a gene involved in speech and language, in the developing and adult striatum. J. 
Neurosci. Res. 73, 61–72. 
 
Teramitsu, I., Kudo, L.C., London, S.E., Geschwind, D.H., and White, S.A. (2004). 
Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional 
interaction. J. Neurosci. 24, 3152–3163. 
 
Thomas, B., Eyssen, M., Peeters, R., Molenaers, G., Van Hecke, P., De Cock, P., and 
Sunaert, S. (2005). Quantitative diffusion tensor imaging in cerebral palsy due to 
periventricular white matter injury. Brain 128, 2562–2577. 
 
Vargha-Khadem, F., Gadian, D.G., Copp, A., and Mishkin, M. (2005). FOXP2 and the 
neuroanatomy of speech and language. Nat. Rev. Neurosci. 6, 131–138. 
 
Vernes, S.C., Spiteri, E., Nicod, J., Groszer, M., Taylor, J.M., Davies, K.E., Geschwind, 
D.H., and Fisher, S.E. (2007). High-throughput analysis of promoter occupancy reveals 
direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am. J. 




Vernes, S.C., Oliver, P.L., Spiteri, E., Lockstone, H.E., Puliyadi, R., Taylor, J.M., Ho, J., 
Mombereau, C., Brewer, A., Lowy, E., et al. (2011). Foxp2 regulates gene networks 
implicated in neurite outgrowth in the developing brain. PLoS Genet. 7, e1002145. 
 
Vitalis, T., Cases, O., Passemard, S., Callebert, J., and Parnavelas, J.G. (2007). 
Embryonic depletion of serotonin affects cortical development. Eur. J. Neurosci. 26, 331–
344. 
 
Vossen, R.H.A.M., Aten, E., Roos, A., and den Dunnen, J.T. (2009). High-resolution 
melting analysis (HRMA): more than just sequence variant screening. Hum. Mutat. 30, 
860–866. 
 
Watkins, K.E., Dronkers, N.F., and Vargha-Khadem, F. (2002). Behavioural analysis of 
an inherited speech and language disorder: comparison with acquired aphasia. Brain 125, 
452–464. 
 
Watkins, K.E., Vargha-Khadem, F., Ashburner, J., Passingham, R.E., Connelly, A., 
Friston, K.J., Frackowiak, R.S.J., Mishkin, M., and Gadian, D.G. (2002b). MRI analysis 
of an inherited speech and language disorder: structural brain abnormalities. Brain 125, 
465–478. 
 
Weinstock, M. (2008). The long-term behavioural consequences of prenatal stress. 
Neurosci. Biobehav. Rev. 32, 1073–1086. 
 
Whitehouse, A.J.O., Bishop, D.V.M., Ang, Q.W., Pennell, C.E., and Fisher, S.E. (2011). 
CNTNAP2 variants affect early language development in the general population. Genes. 
Brain. Behav. 10, 451–456. 
 
Wilson, S.W., Ross, L.S., Parrett, T., and Easter, S.S. (1990). The development of a 
simple scaffold of axon tracts in the brain of the embryonic zebrafish, Brachydanio rerio. 
Development 108, 121–145. 
 
Witteveen, J.S., Middelman, A., van Hulten, J.A., Martens, G.J.M., Homberg, J.R., and 
Kolk, S.M. (2013). Lack of serotonin reuptake during brain development alters rostral 
raphe-prefrontal network formation. Front. Cell. Neurosci. 7, 143. 
 
Xing, L., Hoshijima, K., Grunwald, D.J., Fujimoto, E., Quist, T.S., Sneddon, J., Chien, 
C.-B., Stevenson, T.J., and Bonkowsky, J.L. (2012). Zebrafish foxP2 zinc finger nuclease 
mutant has normal axon pathfinding. PLoS One 7, e43968. 
 
Zeesman, S., Nowaczyk, M.J.M., Teshima, I., Roberts, W., Cardy, J.O., Brian, J., 
Senman, L., Feuk, L., Osborne, L.R., and Scherer, S.W. (2006). Speech and language 
impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2. Am. J. 




RAPID AND EFFICIENT ZEBRAFISH GENOTYPING USING PCR WITH HIGH- 
RESOLUTION MELT ANALYSIS 
 
           The following chapter is reprinted with permission from the Journal of Visualized 
Experiments. Xing, L., Quist, T. S., Stevenson, T. J., Dahlem, T. J., Bonkowsky, J. L. 
Rapid and Efficient Zebrafish Genotyping Using PCR with High-resolution Melt 






Journal of Visualized Experiments www.jove.com
Copyright © 2014  Journal of Visualized Experiments February 2014 |  84  | e51138 | Page 1 of 7
Video Article
Rapid and Efficient Zebrafish Genotyping Using PCR with High-resolution Melt
Analysis
Lingyan Xing1,2,3, Tyler S. Quist1, Tamara J. Stevenson1, Timothy J. Dahlem4, Joshua L. Bonkowsky1,2,3,5
1Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine
2Department of Neurobiology and Anatomy, University of Utah School of Medicine
3Interdepartmental Program in Neurosciences, University of Utah School of Medicine
4Mutation Generation and Detection Core, HSC Core Research Facility, University of Utah School of Medicine
5Department of Neurology, University of Utah School of Medicine
Correspondence to: Joshua L. Bonkowsky at Joshua.Bonkowsky@hsc.utah.edu
URL: http://www.jove.com/video/51138
DOI: doi:10.3791/51138
Keywords: Basic Protocol, Issue 84, genotyping, high-resolution melting analysis (HRMA), PCR, zebrafish, mutation, transgenes
Date Published: 2/5/2014
Citation: Xing, L., Quist, T.S., Stevenson, T.J., Dahlem, T.J., Bonkowsky, J.L. Rapid and Efficient Zebrafish Genotyping Using PCR with High-
resolution Melt Analysis. J. Vis. Exp. (84), e51138, doi:10.3791/51138 (2014).
Abstract
Zebrafish is a powerful vertebrate model system for studying development, modeling disease, and performing drug screening. Recently a variety
of genetic tools have been introduced, including multiple strategies for inducing mutations and generating transgenic lines. However, large-
scale screening is limited by traditional genotyping methods, which are time-consuming and labor-intensive. Here we describe a technique to
analyze zebrafish genotypes by PCR combined with high-resolution melting analysis (HRMA). This approach is rapid, sensitive, and inexpensive,
with lower risk of contamination artifacts. Genotyping by PCR with HRMA can be used for embryos or adult fish, including in high-throughput
screening protocols.
Video Link
The video component of this article can be found at http://www.jove.com/video/51138/
Introduction
Zebrafish (Danio rerio) is a vertebrate model system widely used for studies of development and disease modeling. Recently, numerous
transgenic and mutation technologies have been developed for zebrafish. Rapid transgenesis techniques, usually based on a Tol2 transposon
system1, have been combined with improved cloning options for multiple DNA fragment assembly2. Zinc-finger nucleases (ZFNs) and
transcription activator-like effector nucleases (TALENs) have been used to target loci in both somatic and germline cells in zebrafish3,4. These
techniques can efficiently generate genetically modified animals, with high-frequency mutation creation and germ-line transmission3,4.
Despite these advances, traditional genotyping techniques in zebrafish limit the full power of the mutagenesis and transgenesis tools. PCR
followed by gel electrophoresis, sometimes combined with restriction enzyme digestion, is widely used to detect genome modification, but is
time-consuming and less sensitive to identify small insertions or deletions. TaqMan probe assays have high initial costs and require careful
optimization. Sequencing of PCR products can take several days and is not practical for large-scale screening. Restriction fragment length
polymorphism (RFLP) analysis can only discriminate SNPs affecting a limited range of restriction enzyme recognition sites.
High-resolution melting analysis (HRMA), a closed-tube post-PCR analysis method, is a recently developed method that is rapid, sensitive,
inexpensive, and amenable to screening large numbers of samples. HRMA can be used to detect SNPs, mutations, and transgenes5-7. HRMA
is based on thermal denaturation of double-stranded DNAs, and each PCR amplicon has a unique dissociation (melt) characteristic5. Samples
can be discriminated due to their different nucleotide composition, GC content, or length, typically in combination with a fluorescent dye that
only binds double-stranded DNA8. Thus, HRMA can distinguish different genotypes based on the different melt-curve characteristics. Because
HRMA uses low-cost reagents and is a single-step post-PCR process, it can be used for high-throughput strategies. HRMA is nondestructive,
so following analysis the PCR amplicons can be used for other applications. HRMA has been applied in many organisms and systems, including
cell lines, mice, and humans9-11. Its use has recently been described in zebrafish to detect mutations induced by zinc finger nucleases (ZFNs)
and TALENs6,12,13.
In this paper, we describe how to perform PCR-based HRMA in embryonic and adult zebrafish (Figure 1). This protocol is suitable for detecting
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Protocol
1. DNA Preparation
1. Prepare DNA lysis buffer: 50 mM KCl, 10 mM Tris-HCl pH 8.3, 0.3% Tween 20, 0.3% NP40. Add fresh Proteinase K to a final concentration of
1 mg/ml on the day of use12.
2. Tissue collection:
1. For adult fish fin clip:
1. Anesthetize fish: Place the fish in 0.004% MS-222 (tricaine) solution. Wait until gill movement slows.
2. Put fish on a stack of 5-10 Kimwipes and cut a small piece of the tail fin, about 2-3 mm, with a sterile razor blade.
3. Quickly place the fish in a labeled tank with fresh water for recovery; carefully label both the tank and corresponding tube that will
contain the fin clip. Change the water and feed the fish every other day.
4. Pick up the fin clip with a sterile pipette tip and transfer it into a tube filled with 100 μl DNA lysis buffer.
5. Discard the pipette tip, and discard the razor blade into a sharps container.
2. For embryo tail clip:
1. Place embryos into 0.004% MS-222 (tricaine) solution. Wait 2 min.
2. Cut a piece of tail with forceps under a dissecting microscope.
3. Put the tail into a labeled tube filled with 30 μl DNA lysis buffer.
4. Quickly put the embryo into a tube containing 100 μl 4% paraformaldehyde.
5. Label tubes with embryos and their corresponding tail tubes.
6. Store the tubes with embryos at 4 °C overnight for fixation.
7. Clean the forceps using Milli-Q water and Kimwipes between each embryo to minimize contamination.
3. For whole embryos:
1. Place embryos into 0.004% MS-222 (tricaine) solution. Wait 2 min.
2. Put 1-5 embryos in a tube filled with 100 μl DNA lysis buffer. Dechorionation is not necessary.
3. DNA digestion
Incubate tubes with tissue (fin or tail clips or embryos) at 55 °C for 4 hr up to overnight12.
4. Inactivate the Proteinase K
Heat tubes to 95 °C for 15 min12. DNA should be used for PCR immediately, or stored at -20 °C for up to 3 months.
2. PCR
1. Design Primers either manually or by primer design software (e.g. Lightscanner Primer Design Software- Biofire). PCR products for HRMA
are usually 50-200 bp; PCR products for SNP detection should be smaller, typically 50-80 bp.
2. PCR
1. Perform PCR reaction in a 96-well or 384-well plate.
2. Use 10 μl total volume: 4 μl LightScanner master mix (0.1 U hot-start Taq-AB polymerase, buffer, 0.2 mM dNTPs, 2 mM magnesium
chloride, and 1x fluorescent double-stranded DNA-binding dye); 5 pmol each primer, and 1 μl genomic DNA template extracted from
adult tail fin or 3 μl genomic DNA from embryonic tail13.
3. Cover samples with 30 μl mineral oil.
4. Cover the plate with an optically-transparent adhesive seal.
5. Optimize PCR cycling conditions- typical conditions are 95 °C for 5 min and 30 cycles of 10 sec at 95 °C, 25 sec at 60 °C, 30 sec at 72
°C, ending with 95 °C for 30 sec and cooled to 15 °C.
6. Store PCR plates at 4 °C or continue directly to HRMA.
7. Confirm our PCR product by analysis of its size using agarose gel electrophoresis during initial optimization of PCR; and if indicated, by
sequencing of the PCR product.
3. HRMA
1. Heat plates
1. Place plate in a melt analysis system.
2. Open the software (LightScanner Software Call-IT 2.0).
3. Heat plates from 60-95 °C.
4. Create a new data storage file.
2. Analyze HRMA data (Figure 2).
Multiple steps of analysis are possible. We show the most commonly used set of data manipulations.
1. Subset setting
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1. Select the Normalize tab in the left panel. To eliminate fluorescence variance, manually position the parallel double-line in pre-
(initial) and post (final) -melt regions as illustrated (Figure 2C, arrowheads) and normalize premelt and post-melt fluorescence
signals of all samples to 1 and 0, respectively14.
2. Adjust the positioning of the lines so that the melt region is in the region between the pre- and post-melt lines, but not selected. In
general, the Lower Min and Lower Max (and Upper Min and Upper Max) temperature lines should be placed approximately 1 °C
apart.
3. Choose temperature positions for normalization such that all samples have maximum or full (100%) fluorescence for the premelt
region and minimum or no (0%) fluorescence for the post-melt region (as best as possible). Normalization should result in a
near-horizontal line at the maximum fluorescence of 1 that extends until the melt point and then a near-horizontal line from the
melt point at the minimum fluorescence of 0; there should not be fluorescence levels above 1 or below 0. For example, in Figure
2C, normalize the premelting curves using temperature ranges of 79-80 °C.
3. Grouping/Clustering
Distinguish genotypes based on their melting temperature (Figure 2C, green box). Select Grouping.
1. Select Autogroup from the Standards selection list under the Grouping section.
2. Select Normal or High for melting profiles with single transitions or multiple transitions respectively from the Sensitivity
selection list under the Grouping section.
3. Select Compute Groups under the Grouping section.
4. Go to the File menu and click Save to save the results.
Representative Results
The protocol can be performed during a single day or separated in steps over several days (flow diagram of work is shown in Figure 1). DNA
extraction is followed by the melt and analysis of PCR amplicons. The temperatures for the melt of the amplicon depend on the size and
GC-content, but generally start and end temperatures of 50 ˚C and 95 ˚C are appropriate (Figures 2A and 2B). Once the melt is performed,
analysis of the fluorescence melt curves typically requires normalization of the variation of the different sample curves, using pre- and post-
melt regions as standards (Figure 2C). This improves comparison of results from different samples in which the variation of fluorescence is
related to minor experimental variations. Each pair of temperature lines for normalization should be placed approximately 1 ˚C apart (Figure 2C,
arrowheads). Grouping of data results is represented in two different ways: an upper graph that shows melt curve profiles, and a lower graph that
shows a subtractive difference plot in comparison to a reference sample (Figure 2D).
HRMA analysis can be used to detect mutations (Figures 3A and 3B) or transgenes (Figure 3C). In Figure 3A, two different mutations in
eif2b5 gene are shown (red and blue curves in Figure 3A) by subtracting the normalized fluorescence data of the wild-type sample. It does not
matter which genotype is chosen for reference. More subtle or confusing differences in melt-curves can be distinguished by using the subtractive
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Figure 1. Outline of protocol for PCR-based HRMA of zebrafish genomic DNA. DNA extraction from whole tissue (fin-clip or embryo)
is followed by PCR amplification in the presence of a fluorescent double-stranded DNA-binding dye. The PCR amplicon is denatured and
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Figure 2. Screen-shots of software to perform HRMA and analyze results. A. Screen shot of LightScanner software; yellow box is magnified
in “B”. B. Magnified view of boxed region in “A”. Setting Start and End Temp are shown (arrows). C. Position the premelt and post-melt parallel
lines for normalization (arrowheads). Notice the fluorescence variance in pre- and post-melting regions (red box). Lower graph (green box)
shows melt-curves derived from the raw data plots following normalization. D. Upper graph shows melt curve profiles after automatic grouping;
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Figure 3. Using HRMA to identify mutations and transgenes. Fluorescence difference curves are shown; change in fluorescence (y-axis) to
temperature (x-axis) is shown. A. HRMA was used to detect fish carrying mutations in the eif2b5 gene. Wild type is shown in grey (arrow). Red
and blue colors represent two different eif2b5 mutations, confirmed by sequencing of the PCR product. B. Four different foxP2 mutant alleles
are identified with HRMA. Red: zc82/+ (8 bp deletion), green: zc83/+ (17 bp deletion), blue: zc82/zc83 (8bp deletion/17bp deletion), grey: zc83/
zc83 (17bp deletion homozygotes). C. Gal4 transgenic fish (grey curves) can be distinguished from wild type (brown curve, arrow). Notice that
for transgene detection, normalization should not be performed.  Click here to view larger image.
Discussion
PCR combined with HRMA is a powerful technology for zebrafish genotyping. The advantages of this approach are its speed, robustness, and
sensitivity to detect even point mutations. The entire protocol, from fin-clip to melt-curve analysis, can be performed in less than eight hours by
a single individual. In addition, the technique is amenable for high-throughput screening; does not require the use of ethidium bromide; and is
sealed for all PCR and analysis steps which helps minimize contamination issues.
A critical step for this technique is PCR amplicon and primer design. Typical length for PCR products in HRMA is 50-200 bp. Short amplicons
increase sensitivity and are ideal for detecting single nucleotide changes. If melt-curves of closely related PCR product species can not
be distinguished easily, a small oligonucleotide complementary to the SNP and blocked at the 3’ end can be included in the PCR reaction
(Lunaprobes; probes). The probes are generated by asymmetric PCR using different concentration of the forward and reverse primers, with a
3’ C3 blocker to prevent probe extension in the subsequent HRMA PCR. The probe is then included in the HRMA PCR reaction. HRMA then
occurs with the probe, in which the asymmetric probe binds to the PCR product and generates probe-target duplexes with different melt-curves
that can be used to distinguish alleles.
Several companies offer melt-curve analysis systems. These include the Biofire Lightscanner, the Roche LightcyclerVR 480 and the Qiagen
Rotor-Gene Q. Several fluorescent, DNA-binding dyes are available, including LC Green PLUS and SYT09 EvaGreen. There is some variation
in sensitivity in mutation detection based on different fluorescent dyes and melt-curve machines8,15. Nonsaturating dyes, for example, SYBR
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lower concentrations, SYBR Green I cannot precisely measure melting behavior due to its redistribution from melted regions back to regions of
dsDNA16. In general most existing Real Time PCR platforms are capable of preforming HRMA using a software package add-on and a second-
generation fluorescent DNA binding dye. While technical details of the software and sequence of experimental steps vary slightly between
platforms, the overall scientific concepts are essentially identical.
Our lab and others have demonstrated that HRMA can be used in both embryonic and adult zebrafish to detect transgenes, and mutations
induced by ZFNs and TALENs6,12,13. HRMA has been used to discover polymorphisms in zebrafish6,12. Our lab uses HRMA both for initial
screening of TALEN-induced mutations as well as for sorting of established lines (TSQ and JLB, unpublished). Other potential applications
that could be applied to zebrafish include methylation-sensitive HRMA (ms-HRMA)17, quantification of copy-number variants5; and pathogen
detection in vivariums18.
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Abstract
foxP2, a forkhead-domain transcription factor, is critical for speech and language development in humans, but its role in the
establishment of CNS connectivity is unclear. While in vitro studies have identified axon guidance molecules as targets of
foxP2 regulation, and cell culture assays suggest a role for foxP2 in neurite outgrowth, in vivo studies have been lacking
regarding a role for foxP2 in axon pathfinding. We used a modified zinc finger nuclease methodology to generate mutations
in the zebrafish foxP2 gene. Using PCR-based high resolution melt curve analysis (HRMA) of G0 founder animals, we
screened and identified three mutants carrying nonsense mutations in the 2nd coding exon: a 17 base-pair (bp) deletion, an
8bp deletion, and a 4bp insertion. Sequence analysis of cDNA confirmed that these were frameshift mutations with
predicted early protein truncations. Homozygous mutant fish were viable and fertile, with unchanged body morphology,
and no apparent differences in CNS apoptosis, proliferation, or patterning at embryonic stages. There was a reduction in
expression of the known foxP2 target gene cntnap2 that was rescued by injection of wild-type foxP2 transcript. When we
examined axon pathfinding using a pan-axonal marker or transgenic lines, including a foxP2-neuron-specific enhancer, we
did not observe any axon guidance errors. Our findings suggest that foxP2 is not necessary for axon pathfinding during
development.
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Introduction
Language impairment is central to autism and the autistic
spectrum disorders, and is a major component in many
neurodevelopmental disorders including Angelman syndrome
and Fragile X syndrome [1]. Unraveling the genetic pathways
and neural circuitry involved in language development is
important for understanding these different disorders. However,
only one gene, FOXP2, has been linked specifically with the
normal development of language [2]. This gene, a forkhead-box
transcription factor, was originally identified in a family with
a severe speech and language disorder, and has subsequently been
identified in other patients as well [2–8]. Haploinsufficiency for
FOXP2 in humans leads to defects in grammatical language
construction, as well as in the sequencing of orofacial movements
required for speech articulation [9]. Studies on the human FOXP2
mutant pedigrees, using functional and volumetric magnetic
resonance imaging (MRI), show abnormalities of the basal ganglia,
cerebellum, and prefrontal cortex [10–12].
However, it is not clear what the primary role of FOXP2 in the
central nervous system (CNS) is, nor how that leads to impaired
language development. Further, both pre- and post-natal functions
for FOXP2 have been proposed. In mice, Foxp2 heterozygotes have
impaired motor learning [13], while homozygotes have a smaller
cerebellum [13] and a disorganized Purkinje cell layer in the
cerebellum [14], suggesting a developmental role for Foxp2. In
contrast, knockdown of FoxP2 with lentivirus-mediated RNA
interference (RNAi) in Area X of songbirds leads to inaccurate
vocalizations [15], consistent with a post-natal role.
Additional support for a developmental function of FOXP2 has
come from studies implicating a role for FOXP2 in axon
pathfinding. First, in vitro chromatin immunoprecipitation (ChIP)
showed that CNTNAP2, a member of the neurexin superfamily,
was a target of FOXP2 [16]. CNTNAP2 is associated with specific
language impairment as well as with autism [17–19]. CNTNAP2,
as well as other autism-associated genes, show defects in the
normal development of connectivity [19–21]. Second, ChIP
analysis showed that FOXP2 regulated genes involved in axon
guidance, including EPHA2 and SEMA3B [22,23]. Third, cell
culture studies demonstrated that normal function of Foxp2 was
necessary for neurite outgrowth [24].
We decided to address whether FOXP2 has a role in regulating
axon guidance in vivo. We used a zebrafish model because of its
rapid CNS development and relative ease for imaging and analysis
of axon pathfinding. Zebrafish foxP2 has 86% protein similarity to





human FOXP2 [25], and its CNS expression pattern is conserved
in the telencephalon, basal ganglia, and cerebellum to that of
humans, mice, songbirds, and frogs [25–30]. Previously we had
tried to knock down foxP2 expression using morpholinos in
zebrafish embryos. However, five different morpholinos had
embryonic toxicity, leading to early lethality (JLB, unpublished
data) that was not rescued using a morpholino against p53 [31].
In this paper we generated and screened zinc finger nucleases
(ZFNs) against zebrafish foxP2 using a modified bacterial 1-hybrid
screen. Mosaic G0 injected fish were identified using high
resolution melt analysis (HRMA) PCR of somatic DNA (fin-clip),
and we describe our use of HRMA PCR for screening and
identification of mutants. We generated three frameshift foxP2
mutant alleles: an 8 bp deletion, a 17 bp deletion, and a 4 bp
insertion. The three mutant alleles were homozygous mutant and
fertile, and characterization of CNS development revealed no
changes in apoptosis, proliferation, patterning, or specification. To
analyze pathfinding we used both pan-axonal immunohistochem-
istry, as well as neuron-type specific transgenic reporter lines. We
found that disruption of foxP2 in zebrafish did not affect axon
pathfinding during development. Our results demonstrate the
importance of in vivo validation of ChIP and in vitro studies, and are
concordant with other studies suggesting a role for foxP2 in synapse
development [13,32].
Results
Zinc Finger Nuclease (ZFN) Generation, Injection, and
Screening
We designed ZFNs against a region in exon 2 of the zebrafish
foxP2 cDNA using the target prediction program ZiFiT (http://
bindr.gdcb.iastate.edu/ZiFiT) (Figure 1A). The site in exon 2 was
the only ZFN target 59 of the functional domains including the
forkhead domain and zinc finger domain, as the other acceptable
ZFN sites were 39 to these domains. OPEN pool PCR
amplification, generation of the three-finger zinc finger protein
libraries, reporter plasmid preparation, and bacterial 1-hybrid
screening was performed as described [33]. We screened bacterial
1-hybrid libraries with titers of 2.86107 and 1.16107 cells/plate,
for the right and left fingers, respectively. We picked and
sequenced the selected zinc finger proteins for 10 clones for each
ZFN clone (20 clones total) and compared the amino acid
sequences (Figure 1B, B’). The recovered clones from the library
screening were selected from plates with middle to high stringency:
the concentration of carbenicillin was 100 mg/mL and the
concentration of 3-AT ranged from 20–30 mM. For our final
choice of clones for the left and right ZFNs, we chose the clones
that had the highest percentage of amino acids in common with
the other clones at the specific positions in the zinc finger
(Figure 1C). We hypothesized that this conservation was indicative
of a relative selection for this amino acid at a particular position.
For the ‘‘left’’ ZFN clone (clone #21), every amino acid was found
in at least 50% of the selected clones, and in half of the positions
every clone shared 100% identity. The right ZFN clone (clone
#37) had less conservation, but still 1/3rd of the sites had perfect
conservation.
Clones #37 and #21 were subcloned into the pCS2-FokI-DD
and -RR FokI nuclease expression vectors (pCS2-Flag-TTGZFP-
FokI-DD and pCS2-HA-GAAZFP-FokI-RR [34]), and injected as
mRNA into zebrafish embryos (Figure 2A). Initially we injected
20, 80, and 250 pg of each ZFN into 1-cell stage embryos, and at
48 hours post-fertilization (hpf) assessed the percentage of embryos
that showed a dysmorphic or ‘‘monster’’ appearance [34]. We
found that injections at 80pg each resulted in approximately 50%
dysmorphic embryos, and we used this amount for subsequent
experiments. We confirmed by HRMA PCR (discussed below)
performed on pools of 4–10 embryos each (Figure 2B), and by
subsequent selection of individual clones for sequencing, that we
were inducing mutations in the foxP2 target locus. We raised 25
G0 injected embryos to adulthood, and screened by HRMA PCR
on fin-clip DNA samples. We identified four G0 fish with
abnormal melt-curves in somatic DNA; these fish were crossed
to wild-type fish, and pools of 4 embryos each were screened again
by HRMA PCR. Two of the identified G0 fish did not yield any
mutant offspring, while two fish (of the four) produced mutant
offspring, and were crossed to subsequently give rise to the three
different foxP2 alleles. For the two G0 fish which did not yield
mutant offspring, the mutation may not have been present in the
germline, it may have been present at very low rates, or the
HRMA PCR result may have been falsely abnormal. In the F1
offspring of the two mutant G0 parents, the relative frequency of
mutant offspring was 7% and 25%.
HRMA PCR was performed by designing a small amplicon
centered on the foxP2 ZFN target locus, and performing PCR and
melt-curve analysis of the PCR product [35]. Following amplifi-
cation in the presence of a fluorescent dye that binds double-
stranded DNA, a ‘‘melt’’ of the PCR product either yields a single
peak (Figure 2B, asterisk) corresponding to a single wild-type
product, or to multiple peaks and/or a broader, shifted peak
corresponding to heteroduplexes of wild-type and mutant PCR
product (Figure 2B, arrows), which melt at a lower temperature
[36]. By performing a dilution analysis of mutant DNA into wild-
type DNA, we determined that we could reliably detect mutant
samples when mutant DNA was present in a proportion of 1:20,
but not to 1:50 (Figure 2C-C9, arrowheads). Thus, HRMA PCR
will be able to detect founder G0 fish if mutant cells are present in
more than 1/20–50th of the total cells. Similarly, screening F1
embryos should be limited to no more than 15–20 embryos
concurrently (20 embryos = 40 copies of a genomic locus).
foxP2 Mutant Alleles
We identified three mutant alleles: zc82 (8bp deletion), zc83
(17bp deletion), and zc84 (4bp insertion), which lead to out-of-
frame proteins with early stop codons at amino acids 137, 134, or
164 (out of 697 amino acids) for each mutant (Figure 2D). The
three different alleles each generate a different amino acid
sequence downstream of the mutation prior to the stop, as the
alleles each have a slightly different location of where the deletion
or insertion has occurred. We outcrossed mutant alleles for
successive generations to reduce the potential problem of off-target
mutations [37]. We assessed both in trans heterozygous (hetero-
allelic) and in cis homozygous mutants, but for the experiments
shown here we used heteroallelic mutants in order to avoid
possible off-target background effects. We performed experiments
by crossing heteroallelic parents to one another, and genotyping
their embryos with HRMA. The use of foxP2 heteroallelic mutant
parents prevented possible rescue or amelioration of effects due to
maternal contribution of wild-type transcript from a heterozygous
parent.
To demonstrate that the mutations led to disruption of the
normal transcript we performed RT-PCR followed by sequencing
of the products. We found a single transcript was generated in
mutant embryos which included the mutated exon 2 (Figure 2E).
We cloned and sequenced the PCR product from exon 1–2
amplification, and found that the mutation led to the predicted
shift in codon reading frame. These results suggest that the ZFN-
induced foxP2 mutants will lead to expression of truncated, mutant
protein products lacking the zinc-finger, leucine zipper, and
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forkhead domains. Truncation of human FOXP2 by a premature
nonsense mutation prior to these domains has been shown to lead
to loss of functional protein [38,39], suggesting that our mutations
are in fact nulls.
Homozygous mutant fish were viable and fertile, including both
heteroallelic (foxP2 zc82/zc83, foxP2 zc82/zc84, foxP2 zc83/zc84) and
homozygous (foxP2 zc82/zc82, foxP2 zc83/zc83, foxP2 zc84/zc84) alleles.
There were no obvious changes in overall body morphology of
foxP2 mutants. By in situ analysis, there was no change in foxP2
expression pattern or overall intensity of expression in mutants
(Figure 3 C, D), which is not unexpected since we expect normal
production of mRNA transcript based on the nature of the alleles.
We also measured brain size at 72hpf, and found that mutants had
no difference compared to their wild-type siblings (325 vs. 323 mm,
SEM 3.5 and 2.6, p=0.64) (Figure 3A, B). Further, there were no
changes in foxP2 mutants in the CNS of apoptosis or of
proliferation, as assayed using TUNEL (terminal deoxynucleotidyl
transferase dUTP nick-end labeling) and anti-H3 phosphohistidine
(H3P) antibody at 48hpf and 72hpf, respectively (Figure 4E-H).
CNS development and patterning
To broadly assess CNS patterning we performed in situs for dlx2
and zic2a at 30hpf and 48hpf, respectively. dlx2 and zic2a are
widely expressed and regulate development of many cell types in
the CNS [40–42]. No changes in expression patterns of dlx2 and
zic2a were detected in foxP2 mutants compared to wild-type
(Figure 3E-H). This suggests that foxP2 does not have a role in
overall CNS patterning.
Figure 1. Targeting and selection of ZFNs. (A) foxP2 cDNA sequence, nt 700–725, with target cleavage region in red, and ZFN binding targets
underlined. Codons for design of the left and right zinc finger proteins (ZFP) are shown below with their respective target sequence. (B and B9) Amino
acid sequences of the 10 clones from bacterial 1-hybrid selection, arranged by clone number, zinc finger, and left or right; or (B9) selected clones
shown sequentially. (C) Graphical representation of the relative amino acid frequency compared to other selected ZFN clones, at each position, in the
two ZFN clones chosen for injection.
doi:10.1371/journal.pone.0043968.g001
Figure 2. Flow diagram for generation of ZFN mutants, and HRMA analysis. (A) Flow diagram illustrating steps in generation and
identification of fish carrying ZFN-induced mutation. (B) Illustrative melt-curve (‘‘HRMA’’ high-resolution melt analysis) of F1 generation foxP2 ZFN
fish. Y-axis corresponds to the differential of the change (decrease) in fluorescence; X-axis is the temperature (uC). Each colored line is a different
sample, arrows point to samples with mutations in the foxP2 amplicon; asterisk is the wild-type product. There is some variability in the melt
temperature of the wild-type amplicon because of minor variations in starting template amount and salt concentrations. (C-C9) Melt-curves of
dilutions of mutant foxP2 DNA. Abnormal melt curves (arrowheads) are detected at dilutions of 1:20 mutant:wild-type DNA, but not (or very
minimally) at a dilution of 1:50. (D) Schematic diagram of foxP2 protein domains; asterisk shows the targeted region for ZFN mutagenesis; sequence
above the picture is the nucleotide sequence targeted. Below are shown the three alleles, with the sequence of the mutation, and a picture of the
predicted protein. (E) RT-PCR from wt or foxP2 homozygous mutant embryos at 72hpf, with primers for the full-length transcript, or encompassing
exons 1–2. No alternative splice variants were noted, and sequencing of the foxP2 mutant PCR product showed that the mutations led to the
predicted out-of-frame sequence.
doi:10.1371/journal.pone.0043968.g002
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We examined neuron specification in detail for Purkinje cells
and dopaminergic neurons, because of a proposed role for FoxP2
in their development and function [10–14]. Using immunohisto-
chemistry for calbindin to label Purkinje cells of the hindbrain, and
for tyrosine hydroxylase to label dopaminergic neurons of the
diencephalon, we found no apparent differences in cell morphol-
ogy, number, or organization in foxP2 mutants (Figure 4 A–D).
Therefore, in zebrafish foxP2 does not appear to have a role in
development of cerebellar or dopaminergic neurons.
Foxp2 has also been proposed to regulate synapse formation
[13,32]. We used immunohistochemistry for the pre-synaptic
vesicle protein SV2 [43], and found no difference in neuropil
development in foxP2 mutants (Figure 4 I, J). However, CNTNAP2,
a neurexin-family member identified as an in vitro target of FOXP2
with a potential role in neuronal migration and development of
CNS connectivity [16,19], had decreased expression at 36hpf
(Figure 4K, L, arrows). This decrease was developmentally
persistent and was confirmed by quantitative RT-PCR to be
down-regulated to 72% of normal levels in 72hpf foxP2 mutants
(standard error of the mean 0.078; p,0.05) (Figure 4M). To
confirm the specificity of this effect we injected foxP2 transcript
into mutant embryos at the 1-cell stage transcribed from a full-
length cDNA clone [25]. At 72hpf RNA was prepared from
embryos (wild-type, mutant, or mutant injected with mRNA) that
were morphologically indistinguishable, and a resultant rescue of
cntnap2 levels was found (Figure 4M).
For both the in situs and the RT-PCR of cntnap2 we used
heteroallelic (trans-heterozygous) parents to generate the mutant
off-spring (zc82/zc846zc82/zc84). This was designed to: i.
prevent any maternal mRNA contribution from obscuring results;
Figure 3. foxP2 mutant has normal morphology and CNS
patterning. Whole-mount embryos, brightfield images, scale bar
= 50 mm. Lateral views, rostral to the left (A-F); dorsal views, rostral to
the top (G, H). (A, B) Gross head morphology is unchanged in mutants
at 72hpf. Arrow in (B) shows line used to measure brain size, from the
midbrain-hindbrain boundary to the edge of the head by dissecting the
midpoint of the lens. (C-D) mRNA expression of foxP2 transcript is
unchanged in intensity and pattern in foxP2 mutants. (E-H) in situ
expression patterns and intensity of zic2a and dlx2 is unchanged in
mutants compared to wild-type embryos.
doi:10.1371/journal.pone.0043968.g003
Figure 4. foxP2 does not affect neuron specification, apoptosis,
or proliferation, but does affect cntnap2 expression levels.
Confocal z-stack images, rostral to the top, scale bars 50 mm. (A, B, E-H,
K-L) ventral views. (C, D) dorsal views. (A, B) TH immunohistochemistry
at 72hpf shows no difference in WT and mutants in diencephalic
dopaminergic neuron pattern or number. (C, D) Calbindin immunohis-
tochemistry in the dorsal hindbrain at 72hpf shows similar patterns and
numbers of Purkinje neurons in WT and mutants. (E, F) TUNEL staining
for apoptotic cells at 26hpf in the brain shows no difference in pattern
or number of cells between WT and mutants. (G, H) Detection of
proliferation by H3P staining is similar in WT and mutants at 48hpf. (I, J)
Neuropil distribution and intensity visualized with anti-SV2 synaptic
vesicle protein antibody at 72hpf is similar in WT and mutants. (K, L)
cntnap2 in situ expression pattern at 36hpf shows less expression in
mutant embryos, more noticeably in the telencephalon (arrows). (M)
quantitative RT-PCR at 72hpf confirms decreased expression of cntnap2
in mutants, which is rescued by injection with full-length foxP2 mRNA (*
p,0.05). Y-axis indicates fold-change.
doi:10.1371/journal.pone.0043968.g004
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and ii. to prevent any non-specific background effects of off-target
mutations caused by the zinc-finger nucleases. The wild-types
were generated by crosses between heteroallelic heterozygous
parents (i.e. zc82/+6 zc84/+), and confirmed by HRMA PCR.
Thus although they were not ‘‘litter’’ (clutch) mates, they were of
the same genetic background. Thus, our zebrafish foxP2 mutant
does recapitulate some aspects of CNS dysregulation noted in
other systems.
Axon pathfinding
An outstanding question for foxP2 is whether it regulates the
development of CNS connectivity. To address this, we analyzed
whether foxP2 is required for normal axon pathfinding in vivo. We
used both acetylated tubulin antibody and anti-SV2 to label all
axon tracts, as well as enhancers that specifically express
membrane-targeted GFP in subsets of neurons, including foxP2
neurons (foxP2-enhancerA.2:egfp-caax) [44] and axons of diencephalic
dopaminergic neurons (otpb.A:egfp-caax) [45,46]. We analyzed axon
tracts at 24hpf and 72hpf, including the anterior and post-optic
commissures, optic chiasm, tract of the commissure of the
posterior tuberculum (TCPTc) [47], dopamine neuron projec-
tions, projections to the pituitary, reticulospinal axons, and spinal
cord projections. We did not observe any axon pathfinding errors
in foxP2 mutants (Figure 5 A–R). Our findings show that foxP2
does not play a role in pathfinding during development, assayed
using a variety of markers for different axon tracts.
Discussion
Determining the function of FOXP2 in the CNS has been
difficult, and different groups [13,15,24,28,32] have proposed
a variety of roles, including regulation of synaptic plasticity in
striatal neurons, development of Purkinje cells for motor-skill
learning, and the control of connectivity development [24].
However, studies have been constrained by the use of primarily
in vitro data, or by a lack of analysis of early CNS development,
including basic patterning. Further, no analysis has been done
whether FOXP2 controls the development of axon pathfinding.
Since in humans language ability depends on connections between
different language areas [48], we had hypothesized a role for
FOXP2 in axon guidance.
In the work we generated foxP2 mutants in zebrafish using
a modified zinc finger nuclease (ZFN) protocol [33], and recovered
3 mutants alleles from 25 injected G0 fish. The use of ZFN
technology in zebrafish is important for analysis of gene function.
For example, our own previous analysis of foxP2 in zebrafish using
morpholinos led to conflicting results: 5 of 6 different morpholinos
had a severe, early embryonic phenotype with tissue necrosis that
began shortly after gastrulation, whereas a 6th morpholino caused
no observable phenotype. We demonstrated that in the foxP2
mutant alleles we only had mutant mRNA transcript generated,
with no evidence for alternate splicing. While we can not exclude
the possibility that other foxP2 splice variants might be generated
that lack the ZFN-induced mutation of exon 2, at least during this
critical time period of axon pathfinding we only obtain a single
RT-PCR product that contains exon 2.
We tried a variety of commercially available antibodies
generated against mouse and human FoxP2, as well as a polyclonal
antibody directed against two different peptide epitopes from the
zebrafish foxP2 protein, we were unable to find an antibody that
was specific (JLB, LX, data not shown). In particular, with the
polyclonal antibodies we raised against zebrafish peptide epitopes,
there was no signal above background on whole-mount or cryostat
section immunohistochemistry. On western blots, the zebrafish-
directed antibodies gave numerous bands that did not correspond
in size to the predicted zebrafish foxP2 protein. Following pre-
incubation with the peptides used to raise the antibodies, there was
no loss of an obvious band that might correspond to foxP2. The
lack of demonstration of a protein null is a limitation. However,
our indirect evidence based on RT-PCR and sequencing, as well
as the down-regulation of cntnap2 and the ability of full-length
foxP2 transcript to rescue the cntnap2 phenotype, argue that our
alleles are mutants.
Figure 5. foxP2 does not affect axon pathfinding. Confocal z-stack images of whole-mount embryos, scale bars 50 mm, show no difference
between wild-type and foxP2 mutant (2/2) embryos for axon pathfinding using a variety of axonal labels. (A–D) anti-SV2 immunohistochemistry at
24hpf, lateral views of the brain, rostral to the left (A, B) and 72hpf, dorsal views of the spinal cord, rostral to the top (C, D). (E, F) anti-acetylated
tubulin immunohistochemistry at 72hpf, ventral views of the optic chiasm. (G-L) GFP immunohistochemistry at 72hpf in Tg(foxP2-enhancerA.2:egfp-
caax) embryos that labels foxP2 neurons show no pathfinding errors in anterior commissure (ac), longitudinal commissures (lc), tract of the
commissure of the posterior tuberculum (TCPTc), or reticulospinal axons (rs). (M-R) GFP immunohistochemistry at 72hpf in Tg(otpb.A:egfp-caax)
embryos for visualization of dopaminergic and neuroendocrine projections (M, N, with insets shown in O, P) in the brain, and dopaminergic axon
tracts in spinal cord (Q, R).
doi:10.1371/journal.pone.0043968.g005
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In addition, our ability to efficiently detect mutant fish was
enhanced by our use of HRMA PCR analysis, including screening
the G0 fish by analysis of somatic (fin-clip) DNA. This permitted
us to analyze a subset of the G0 fish and limit the number of
different animals that we needed to cross and screen. HRMA
permits rapid genotyping, and we were able to use the patterns of
the different melt-curves to distinguish between the different foxP2
alleles we generated. Using fin-clip followed by HRMA PCR of
G0 fish offers a potential short-cut to detect ZFN founders.
However, in our experiments we did not examine the founder rate
in G0 fish that were fin-clip PCR negative. Thus, we can not
exclude the possibility that our method does not enrich for
founders and instead reflects chance.
In contrast to work on Foxp2 in mouse, we found that the foxP2
mutant zebrafish were viable and fertile, with no changes in CNS
patterning or specification, normal axon pathfinding, and minor
changes in synapse development. We did not find any abnormal-
ities in specification of Purkinje or dopamine neurons, or in
cerebellar development [13,14,32]. We also examined in detail
effects of loss of foxP2 on apoptosis, patterning, and CNS
patterning and specification, and found no effects in mutant
animals. While we can not exclude that foxP2 might exert more
subtle effects on axon pathfinding that our assays did not detect,
we have demonstrated that our transgenic lines can detect
relatively minor axon pathfinding errors in other experimental
paradigms [49].
What explains the difference in phenotypes from zebrafish to
mouse? These results are unlikely to be explained by the presence
of a second closely related protein in zebrafish, since genomic
sequence data as well as our own RT-PCR results do not show any
evidence for a second foxP2 ortholog (JLB, unpublished). There are
two foxP1 orthologs in zebrafish (JLB, unpublished data; [50]), and
as FoxP1 can act cooperatively with FoxP2 [51,52], it is possible
that the foxP1 orthologs in zebrafish could functionally compensate
for loss of foxP2. However, it is not clear then why in mouse Foxp1
is unable to compensate for Foxp2 function. Finally, foxP2’s role in
CNS development may have changed over evolution, with
a critical role in mouse viability, for example in lung development
[52].
Our two primary findings were first, that foxP2 mutants did not
have changes in axon pathfinding. This is in contrast to the results
suggesting a role for Foxp2 in neurite outgrowth, and in regulation
of axon guidance genes [24]. This finding must be tempered in
that we can not exclude an axon guidance role for foxP2 that is
compensated by one of the foxP1 orthologs. Second, we found that
in foxP2 mutants there was a decrease in cntnap2 expression levels,
which is opposite to the cell culture results showing that loss of
FOXP2 led to an increase in CNTNAP2 expression [16]. Our
results suggest caution in interpretation of in vitro data, although it
is possible that zebrafish foxP2 has different CNS roles than mouse
Foxp2. However, given the conservation of expression domains and
protein similarity in zebrafish, argue at least in part against a widely
divergent CNS function of foxP2 in zebrafish. Future studies with
foxP2 will need to examine in greater detail its role in synaptic
development, given our findings of decreased cntnap2 expression




All zebrafish experiments were performed with supervision and
in strict accordance of guidelines from the University of Utah
Institutional Animal Care and Use Committee (IACUC), regulat-
ed under federal law (the Animal Welfare Act and Public Health
Services Regulation Act) by the U.S. Department of Agriculture
(USDA) and the Office of Laboratory Animal Welfare at the NIH,
and accredited by the Association for Assessment and Accredita-
tion of Laboratory Care International (AAALAC). This study was
approved by the University of Utah IACUC (protocol #11–
06005).
Fish stocks and embryo raising
Adult fish were bred according to standard methods. Embryos
were raised at 28.5uC in E3 embryo medium and staged by time
and morphology [53]. For in situ or immunohistochemistry
staining, embryos were fixed in 4% paraformaldehyde (PFA) (in
PBS) overnight (O/N) at 4uC, washed briefly in PBS, dehydrated
stepwise from PBS to 100% MeOH, and stored in 100% MeOH
at 220uC until use.
Transgenic fish lines used in this paper were the following:
Tg(otpb.A:egfp-caax) (official ZFIN nomenclature Tg(otp-
b:1EGFP)zc49) [e3] and Tg(foxP2-enhancerA.2:egfp-caax)zc69 [44,49].
foxP2 mutant alleles are zc82 (8 bp deletion), zc83 (17 bp deletion),
and zc84 (4 bp insertion) (Figure 2). Injection of DNA constructs
and raising of stable transgenic lines was performed as described
[44,54,55]. Lines are available upon request. Mutant allele
sequences have been deposited in ZFIN.
In situ hybridization and Immunohistochemistry
Whole-mount in situ labeling and immunohistochemistry were
performed as described [25,44]. Antibodies and dilutions were
rabbit polyclonal anti-tyrosine hydroxylase 1:400 (Millipore);
mouse anti-acetylated tubulin 1:250; goat anti-mouse Alexa 488
1:500 (Invitrogen); rabbit anti-calbindin 1:150 (Swant); rabbit anti-
H3P (Millipore), 1:500; mouse anti-SV2 (Developmental Studies
Hybridoma Bank) 1:300; and Cy-3 anti-rabbit 1:400. Apoptotic
cells were stained with TUNEL (Millipore) as described [56].
Microscopy and image analysis
Image acquisition and analysis were performed as described
previously [44]. Embryos were processed and placed in a solution
of 80% glycerol/20% PBST, and mounted on a glass slide with
a #0 coverslip. NIH ImageJ software was used to merge slices to
create maximal intensity z-stack projections. Brain size was
calculated using whole-mount images of embryos at 72hpf;
distance was calculated in ImageJ from the midbrain-hindbrain
boundary to the edge of the head by a line dissecting the midpoint
of the lens (Figure 3B).
cDNA and quantitative RT-PCR
Total RNA from 72hpf embryos was extracted using Trizol
(Invitrogen), purified (Qiagen RNeasy mini-columns), and reverse-
transcribed (SuperscriptTM III First-strand Invitrogen kit).
Primers for foxP2 were used to amplify either the entire coding
region (forward 59-AGCAGTGAAGTAAGCGCAGTCGA-39;
reverse: 59-AGCGGCAAAGTGGTCTCCGC-39), or the region
encompassing exons 1 and 2 (forward primer: 59-AGCAGT-
GAAGTAAGCGCAGTCGA-39; reverse primer: 59-
CGCTGTTTGTCGTTGTTCTTTGG-39). PCR product of
exon 1–2 amplification from foxP2 homozygous mutants were
cloned and sequenced.
RT-qPCR reaction for cntnap2 was performed on 72hpf
embryos on two separate occasions. The reaction mix included
SYBR Green, primers, and cDNA templates; conditions were
95uC for 10 min, followed by 38 cycles of 95uC for 30 s, 60uC for
30 s and 72uC for 30 s. Each reaction was performed in triplicate
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and the mean of replicates was calculated; results were normalized
to the mRNA level of cntnap2 in wild-type embryos with b-actin
transcript levels as a control using the Pfaffl method [57]. Primers
were forward 59- CCAGCTGTTTGTAGGTGCTTCGGG-39
and reverse 59- CGCACCAGCGTCCCACTCTC-39.
DNA preparation, Genomic DNA PCR, HRMA, and
Dilution Analysis
Genomic DNA was prepared as described [35]. PCR reactions
were performed in 96-well, hard-shell plates (Bio-Rad, Inc.) in
10 ml volume: 4ml master mix including Taq polymerase, dNTPs,
magnesium chloride, and fluorescent double-stranded DNA
binding dye (LCGreen PLUS) (Lightscanner Master Mix- Idaho
Technology, Inc.), 5 pmol each primer (forward primer: 59-
CCTACAAGCAGCAAGGCA-39; reverse primer: 59-
TGTCGTTGTTCTTTGGAGATT-39), and genomic DNA
template extracted from DNA lysis buffer [35]. PCR reactions
were covered with 30 ml mineral oil. PCR cycling conditions were:
2 min at 95uC, followed by 28 cycles of 10s at 95uC, 25 s at 61uC,
ending with 95uC for 30 s and cooled to 15uC. HRMA was
performed on a LightScanner-96 instrument (Idaho Technology,
Inc.), from 60uC to 97uC with a temperature transition rate of
0.1uC/s. The melt curves were normalized using temperature
ranges of 74–75uC and 87–88uC. Genotypes can be distinguished
on the basis of their respective melt temperatures [58]; following
initial confirmation by DNA sequencing.
Dilution analyses were performed in triplicate. Genomic DNA
was prepared in the standard fashion; DNA concentrations were
determined, and corresponding amounts of wild-type and foxP2
mutant DNA were then mixed. Dilutions of 1:2, 1:5, 1:10, 1:20,
1:50, and 1:100, mutant:wild-type DNA sample were prepared,
and HRMA PCR was then performed.
OPEN selection of zinc finger arrays and bacterial 1-
hybrid selection
We designed ZFNs against a region in exon 2 of the zebrafish
foxP2 cDNA using the target prediction program ZiFiT (http://
bindr.gdcb.iastate.edu/ZiFiT) (Figure 1A). OPEN pool PCR
amplification, generation of the three-finger zinc finger protein
libraries, reporter plasmid preparation, and bacterial 1-hybrid
screening was performed as described [33]. Final ZFN clones were
prepared in pCS2-FokI-DD and pCS2-FokI-RR nuclease expres-
sion vectors (pCS2-Flag-TTGZFP-FokI-DD and pCS2-HA-
GAAZFP-FokI-RR were from Addgene, plasmids #18755 and
18754); transcribed mRNA was injected into 1-cell stage zebrafish
embryos at 80pg each.
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A SEROTONIN CIRCUIT ACTS AS AN ENVIRONMENTAL SENSOR TO 
MEDIATE MIDLINE AXON CROSSING THROUGH EPHRINB2 
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         Modulation of connectivity formation in the developing brain in response to 
external stimuli is poorly understood. Here, we show that the raphe nucleus and its 
serotonergic projections regulate pathfinding of commissural axons. We found that the 
raphe neurons extend projections towards midline crossing axons, and that when 
serotonergic signaling is blocked by pharmacological inhibition or by raphe neuron 
ablation, commissural pathfinding is disrupted. We demonstrate that the serotonin 
receptor htr2a is expressed on these commissural axons, and that genetic knock-down of 
htr2a disrupts crossing. We further show that knock-down of htr2a, or ablation of the 
raphe neurons, increases ephrinB2a protein levels in commissural axons. An ephrinB2a 
mutant can rescue midline crossing when serotonergic signaling is blocked. Furthermore, 
we found that regulation of serotonin expression in the raphe neurons is modulated in 
response to the developmental environment. Hypoxia causes the raphe to decrease 
serotonin levels, leading to a reduction in midline crossing. Increasing serotonin in the 
setting of hypoxia restored midline crossing. Our findings demonstrate an instructive role 
for serotonin in axon guidance acting through ephrinB2a, and reveal a novel mechanism 





 Current models propose that neural circuitry development in the vertebrate brain 
is governed by an early life genetic program that constrains the range of potential 
connectivity and behaviors, but then is refined by experience-driven neuronal activity to 
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refine this template (Katz and Shatz, 1996). Recent evidence also shows a role for 
neuronal activity in the development of normal connectivity (Hanson and Landmesser, 
2004;  Suárez et al., 2014). However, it is not known whether intrinsic mechanisms exist 
to modulate developing CNS connectivity in response to exogenous developmental or 
environmental cues.  
 In the adult CNS the neurotransmitter serotonin (5-HT) is known to act as a 
molecular mediator of plasticity (Celada et al., 2013; Jitsuki et al., 2011). Intriguingly, in 
early development 5-HT neurons and their axon projections are widespread in the 
vertebrate CNS. Projections from the 5-HT raphe nuclei (nuclei B1-9) (Dahlström and 
Fuxe, 1964) arborize throughout the CNS (Steinbusch, 1981), including ascending 
projections in the telencephalon and descending innervation of the brainstem and spinal 
cord. Innervation occurs early in development (Lillesaar et al., 2009; Rubenstein, 1998), 
prior to the development of behaviors requiring 5-HT; and prior to 5-HT’s roles in the 
refinement of sensory maps (Lesch and Waider, 2012; Toda et al., 2013).  
 These findings suggest a non-classical role for 5-HT in early development. Recent 
work has shown that 5-HT is necessary for neuron migration, dendrite arborization, and 
synapse formation (Matsukawa et al., 2003; Persico et al., 2001; Riccio et al., 2009; 
Vitalis et al., 2007;). A potential role in pathfinding has also been observed. In mouse 
thalamocortical neuron explants 5-HT caused a repulsive response to netrin-1, and over-
expression of the 5-HT receptor htr1B/1D caused dorso-ventral shifting of the axon tracts 
(Bonnin et al., 2007). In rat raphe neuron explants, knockdown of the 5-HT transporter 
caused altered fasciculation and projections of axons (Witteveen et al., 2013).  
 Precise mechanisms and roles for 5-HT in pathfinding are poorly understood. Is 
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5-HT a modulator to fine-tune axon guidance, or does it play a more instructive role in 
pathway choice?  Since 5-HT signaling activates second messenger systems, how is 
specificity of action achieved?  5-HT has been shown in Aplysia to increase expression of 
neurexin and neuroligin at the synapse by increased kinesin-mediated transport ( Choi et 
al., 2011; Puthanveettil et al., 2008), supporting the possibility of a role for 5-HT in 
regulating cell-surface receptors responsible for axon guidance.   
 Another unresolved feature is whether in vertebrates neural connectivity can be 
modulated during development, for example by changes in 5-HT. Altered behavior in C. 
elegans can be caused by changes in 5-HT expression from environmental manipulation, 
apparently by alterations in neuropeptide and receptor expression in an extant neural 
circuit (Pocock and Hobert, 2010). In vertebrates no similar mechanism has been noted.  
A role for 5-HT in interpreting exogenous stimuli and altering neural circuits during 
development would represent an unexpected means for altering an organism’s 
neurobehavioral repertoire in response to parental or developmental exposures. 
 To investigate a role for 5-HT in neural circuit development we applied the 
experimental tractability of the small vertebrate zebrafish (Danio rerio) to visualize axon-
guidance decisions. Here we report that pharmacological blockade of 5-HT signaling, 
genetic ablation of the raphe neurons, or knock-down of 5-HT receptors lead to failure of 
midline axon crossing of telencephalic neurons. We further demonstrate that 5-HT’s axon 
guidance role is mediated by downregulation of ephrinB2a (efnB2a) levels, as loss of 5-
HT signaling led to increased efnB2a levels, which caused failure of commissural axons 
to cross the midline. 5-HT expression is decreased by hypoxia; restoration of serotonergic 
signaling rescued hypoxic-mediated disruption of midline axon crossing. Our results 
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show that raphe 5-HT neurons act as a sensor to alterations in the developmental milieu, 
and their projections regulate pathfinding of a separate circuit. Thus, our study 
demonstrates an instructive role for 5-HT in axon pathfinding, and identifies a novel 
mechanism of connectivity development in the CNS. 
 
Materials and methods 
Ethics statement 
 All zebrafish experiments were performed in accordance of guidelines from the 
University of Utah Institutional Animal Care and Use Committee (IACUC), regulated 
under federal law (the Animal Welfare Act and Public Health Services Regulation Act) 
by the U.S. Department of Agriculture (USDA) and the Office of Laboratory Animal 
Welfare at the NIH, and accredited by the Association for Assessment and Accreditation 
of Laboratory Care International (AAALAC). 
 
Fish stocks and animal husbandry 
Adult fish were bred according to standard methods. Embryos were raised at 
28.5°C in E3 embryo medium with methylene blue, and embryos beyond 24 hpf were 
treated with phenylthiourea (PTU) to prevent pigment formation. For in situ staining and 
immunohistochemistry, embryos were fixed in 4% paraformaldehyde (PFA) in PBS 
overnight (O/N) at 4°C, washed briefly in PBS with 0.1% Tween-20, dehydrated 
stepwise in MeOH (25%, 50%, 75%, 100%), and stored in 100% MeOH at -20°C until 
use. Transgenic fish lines and alleles used in this paper were the following: Tg(foxP2-
enhancerA.2:egfp-caax)zc69 (Stevenson et al., 2012); Tg(foxP2-enhancerA.2:Gal4-
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VP16413-470)zc72 (Stevenson et al., 2012); Tg(myl7:EGFP;UAS:TagRFP-caax)zc61; 
efnb2ahu3393/+ (Kettleborough et al., 2013; ENSDARG00000020164#hu3393);  
Tg(UAS:Eco.NfsB-mCherry)rw0144 (referred to as Tg(UAS:NTR-mCherry)) (Davison et 
al., 2007); Tg(tph2:GAL4FF)y228Tg (Yokogawa et al., 2012); Tg(fev:GAL4-GFP)gy1 
(generated from the -3.2pet1 enhancer, Lillesaar et al., 2009). Lines are available upon 




 For induction and monitoring of hypoxia, embryonic zebrafish were placed in a 
sealed plexiglass chamber connected via a controller that monitored and adjusted 
nitrogen gas flow to a desired pO2 set point (Biospherix Ltd.), using previously 
established protocols (Stevenson et al., 2012). Embryos were incubated in 1% O2 from 
24-36 hpf. Morphological staging was used to determine age at fixation for analysis. 
 
Scoring TCPT axon errors; C/L1 and C/L2 intensity ratios 
 Evaluation of TCPT midline axon crossing defects was determined as previously 
described (Stevenson et al., 2012) with the following modifications: we measured the 
total fluorescence intensity (average intensity x area) of a rectangular area placed over the 
commissure or longitudinal tract. The rectangle (set size, 10 x 30 pixels in ImageJ) was 
placed over the midline of the commissural TCPT pathway or over the longitudinal axons 
immediately rostral to (L1) or caudal to (L2) their decussation into the TCPT. A confocal 
z-stack of 10 slices (step size 2 µm) was taken of the region using identical confocal 
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settings (20x objective, PMT range 400-600, imaging speed 12.5 ms/pixel), then we 
calculated the fluorescence of the average intensity projection. A ratio of the commissural 
vs. longitudinal axon intensity was calculated (C/L1, C/L2 ratio) (Figure 4.2D). Some 
experimental variation was noted, and so results were only directly compared for 
experiments performed on the same day.   
 
Immunohistochemistry and in situ hybridization 
            Immunohistochemistry was performed as previously described (Bonkowsky et al., 
2008;  Stevenson et al., 2012; Xing et al., 2012). Antibodies used were: mouse anti-
tubulin 1:250 (Developmental Studies Hybridoma Bank, 6G7), mouse monoclonal a-GFP 
1:250 (Millipore, MAB3580), goat polyclonal a-ephrinB2a 1:20 (R&D Biosystems, 
AF1088), rabbit a-serotonin 1:500 (ImmunoStar, 20080), mouse a-HuC/D 1:250 
(Molecular Probes, A21271), rabbit a-TagRFP 1:250 (Evrogen, AB234), Cy-3 a-rabbit 
1:400 (Millipore, AP132C), Alexa 488 donkey a-mouse 1:400 (Invitrogen, A21202), 
Alexa 555 rabbit a-goat 1:100 (Invitrogen, A21429).   
Tubulin immunohistochemistry was performed by fixation in 2% trichloroacetic 
acid overnight at 4°C. Embryos were washed with PBST four times for 5 minutes each, 
blocked for 1 hour (Roche western blocking reagent, 11921673001), and incubated with 
mouse a-tubulin overnight at 4°C. After PBST washes, embryos were incubated with 






Quantification of 5-HT in hypoxia/normoxia 
             Images were obtained with identical confocal settings for all embryos. Intensities 
were calculated in a rectangle of set size (70 x 100 pixels in ImageJ) placed over the 
raphe nuclei (rostral edge of the rectangle was placed at the rostral-most 5-HT raphe 
neurons) using average intensity projections of 5 z-slices (step size 2 µm). HuC/D 
intensity was also measured with the same z projections. 5-HT intensity level was 
normalized to HuC/D.  
 
Quantification of ephrinB2a levels 
             a-ephrinB2a staining intensity was determined in control and ketanserin-treated 
embryos at 36 hpf; or control and Mtz-treated embryos at 64hpf; confocal images were 
obtained with identical confocal settings. Intensities were calculated in rectangles of fixed 
size, in control/ketanserin over the telencephalon (78 x 72 pixels), diencephalon (24 x 50 
pixels), or lens (74 x 107 pixels), using average intensity projections of 11 z-slices 
starting at the equator of the lens and then extending 5 steps in dorsally and ventrally (11 
z-slices total; step size 2 µm); and in control/Mtz, rectangles were over the telencephalon 
(85 x 110 pixels), diencephalon (34 x 64 pixels), and lens (105 x 165 pixels) using 
average intensity projections of 5 z-slices (5 slices from ventral-most edge of the lens; 
step size 2 µm). 
 
In situ hybridization 
 Antisense digoxigenin-labeled RNA probes were prepared for tph2 
(ENSDARG00000057239), htr2ab (ENSDARG00000058165), htr2aa 
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(ENSDARG00000057029), and htr2c (ENSDARG00000018228) using standard 
methods (Bonkowsky and Chien, 2005). Probe for tph2 was made from pCR2.1TOPO z 
tphR (tph2) D75 (from L. Bally-Cuif). To generate the htr2ab, htr2aa, and htr2c probes, 
cDNA from 3 dpf larvae was amplified with primers as follows: htr2ab, forward: 5’- 
GCAATGGGAGCGAAGAGAGA-3’; reverse: 5’-GGCCAGGTGTAACCGTAGAG-3’. 
htr2aa, forward: 5’-TCACACCTCCTTTTGGACGG-3’; reverse: 5’-
TTAGCATTGCACGCATTCGG-3’; htr2c, forward: 5’-
TAGACCTCGTTGGCTGGATG-3’; reverse: 5’-CACTAGAATCAGCAGGGCCG-3’. 
After gel purification, the fragment was cloned into a pCR4-TOPO TA vector 
(Invitrogen) and sequenced to confirm its identity. To make an antisense probe, the 
construct was linearized with SpeI and transcription performed using T7 polymerase. 
 
In situ hybridization combined with immunohistochemistry on sections 
            In situ hybridization was performed as described above. After the in situ was 
completed, embryos were sequentially transferred to 5%, 15% and then 30% sucrose (in 
PBS). Embryos were then embedded in optimal cutting temperature compound (OCT, 
Tissue-TeK, 4583) using a dry ice ethanol bath, and stored at -80°C at least overnight. 20 
µm sections were cut for immunostaining. Sections were boiled for 20 minutes with 
citrate buffer (10 mM sodium citrate, 0.05% Tween-20, pH 6.0) for antigen retrieval, then 
blocked for 30 minutes (1% BSA, 0.1% fish skin gelatin (Sigma G7765), 0.1% Tween-20 
in PBS). The sections were incubated with primary antibody mouse a-GFP 1:100 at room 
temperature for one hour. After washing of the primary antibody with PBS 3 x 5 minutes, 





Sparse and ipsilateral neuron labeling 
One-cell stage embryos were co-injected with plasmids for UAS-lyn-TagRFP 
(Yokogawa et al., 2012) and foxP2-enhancerA.2:Gal4 (Stevenson et al., 2012). 25 pg of 
each plasmid was injected per embryo.  
 
Microscopy, image analysis, and movie analysis 
 Image acquisition and analysis were performed as described previously 
(Bonkowsky et al., 2008).  For 3-D images, confocal images were processed with 
FluoRender (Wan et al., 2012). Rendered images were exported as TIFFs and converted 
into avi files using ImageJ. 
 
Morpholino injections and htr2ab mRNA expression analysis 
 One-cell stage embryos were injected with either 6 ng htr2aa, 6 ng htr2ab, or 2 
ng htr2c splice-blocking morpholino (Gene Tools, Inc.). RT-PCR to test splice-blocking 
of morpholinos was performed as previously described (Xing et al., 2012). Sequences for 
the morpholinos were htr2ab mo:5’-ATGTAAAGAAACTCACCGTAGAGGA-3’ 
(targeting gene ENSDARG00000058165); htr2aa mo: 5’-
TAACCTGAAGAGGAGATACACATGC-3’ (targeting gene ENSDARG00000057029); 
and htr2c mo: 5’- TCAAATCCGTGTTTCTCTGACCTAT-3’ (targeting gene 
ENSDARG00000018228). RT-PCR to test splice-blocking of morpholinos was 
performed as previously described (Xing et al., 2012). Primers for testing htr2ab 
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morpholino efficacy were used to amplify the region encompassing exons 1 and 3 




 Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) was 
performed on whole-mount larvae (ApopTag Fluorescein in situ Apoptosis Detection Kit; 
Millipore) as described (Lambert et al., 2012).  
 
Drug treatment 
 Embryos were manually dechorionated at 24hpf.  E3/PTU-containing solution 
was mixed with the respective compound: 500 mM ketanserin (Sigma, S006), 2 mM 
fluoxetine (Sigma F132), or 200 mM methysergide (Sigma, M137). Embryos were 
incubated with the compound from 24-72 hpf. Fixation with 4% PFA occurred at 72 hpf.  
Metronidazole (Mtz) (Sigma catalog no. M1547) was dissolved in 0.05% or 0.2% DMSO 
in standard E3/PTU-containing solution. Before 24 hpf, embryos were exposed to 5 
mM Mtz in 0.2% DMSO. At 24 hpf, embryos were manually dechorionated, and exposed 
to 5 mM Mtz in 0.05% DMSO from 24-96 hpf. Fixation with 4% PFA occurred at 96hpf.  
 
Quantitative RT-PCR 
 qPCR for tph2 was performed on 36 hpf and 48 hpf embryos. Each reaction was 
performed in triplicate and the mean of replicates was calculated; results were normalized 
to the mRNA level of tph2 in wild-type embryos with β-actin transcript levels as a 
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control. qRT-PCR reaction for ephrinB2a was performed on 48hpf embryos. Primers for 
tph2 were forward 5′-TTTGTGGAGGTTGCAATGAA-3′ and reverse 5′- 
CAGTCCAGCCAGGAAGTCTC-3′. Primers for β-actin were forward 5′-
CTCTTCCAGCCTTCCTTCCT-3′ and reverse 5′- CACCGATCCAGACGGAGTAT-3′. 
qRT-PCR reaction for ephrinB2a was performed on 48hpf embryos. Primers for 




 One-cell stage embryos from a mating of Tg(foxP2:egfp-caax) outcrossed to wild 
type were injected with 1 ng Cas9 protein (PNA Bio, CP01) and 600 pg htr2ab sgRNA 
(Jao et al., 2013). sgRNA was targeted to the following sequence in htr2ab: 
GGTCATAATCATCACCGTGA. sgRNA synthesis followed the protocol as previously 
described (Jao et al., 2013). Embryos were collected at 24 hpf for mutation analysis using 
PCR and high-resolution melt analysis (HRMA) (Xing et al., 2012; Xing et al., 2014).  
 Genomic DNA from 24 hpf embryos was prepared as follows: embryos were 
incubated with 30 µl 50 mM NaOH at 95°C for 25 minutes; then cooled to 4°C, then 3 µl 
1M Tris-HCl (pH8.0) was added. PCR reactions were performed in 96-well hard-shell 
plates (Bio-Rad, Inc.) in 10 µl volume: 4 µl 2.5x LightScanner Master Mix (Idaho 
Technology, Inc.), 5 pmol each primer (forward primer: 5′-
GTCCAGAAGAACTGGGTGGC-3′; reverse primer: 5′-
CTGGTCATCATGGCGGTGAG-3′), and 3 µl genomic DNA template extracted above. 
PCR reactions were covered with 30 µl mineral oil. PCR cycling conditions were: 2 min 
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at 95°C, followed by 28 cycles of 10 s at 95°C, 30 s at 68°C, ending with 95°C for 30 s 
and cooled to 15°C. HRMA was performed on a LightScanner-96 instrument (Idaho 
Technology, Inc.), from 60°C to 97°C with a temperature transition rate of 0.1°C/s. For 
sequencing the targeted region in F0 founders, PCR amplicons were cloned into the 
pCR4-TOPO TA vector (Invitrogen). Plasmids were isolated from individual colonies 
and Sanger sequenced. 
 
Results 
5-HT blockade causes commissural axon pathfinding errors 
 To study the role of 5-HT in axon pathfinding, we used the transgenic line 
Tg(foxP2-enhancerA.2:egfp-caax), which expresses membrane-targeted GFP in a 
subset of neurons in the telencephalon (Stevenson et al., 2012). Tg(foxP2-
enhancerA.2:egfp-caax) neurons project axons in the anterior commissure, longitudinal 
pathways, and the diencephalic tract of the commissure of the posterior tuberculum 
(TCPTc) (Wilson et al., 1990). The TCPTc axons start to extend at 24 hpf (hours post-
fertilization); by 36-48 hpf axons are preparing to cross the midline; most axons have 
crossed by 72 hpf; and the commissure is fully formed by 96 hpf (Figure 4.1 A-D). To 
clarify the targets and pathways of these axons, we performed ipsilateral sparse labeling 
of the neurons labeled by foxP2-enhancerA.2 by transient expression of co-injected 
plasmids, foxP2-enhancerA.2:Gal4 and UAS:lyn-TagRFP (Stevenson et al., 2012; 
Yokogawa et al., 2012) into one-cell stage embryos. We observed three different 
projection classes: a subset of axons that cross the midline as the TCPTc and target onto 










Figure 4.1. Axons labeled by foxP2-enhancerA.2:egfp-caax and the TCPT commissure. 
Confocal images of whole-mount embryos, rostral top, scale bar, 50 µm. A-D) 
Tg(foxP2-enhancerA.2:egfp-caax) embryos, maximum intensity z-stack projections, a-
GFP immunohistochemistry. A-C) Midline TCPT commissure (TCPTc) axon crossing 
begins around 36-48 hpf (arrowhead). D) By 72hpf the TCPTc is formed (arrow). E) 
Schematic illustration of three major axon pathways of foxP2-enhancerA.2 neurons. 1, 
longitudinal axons; 2, TCPTc, tract of the commissure of the posterior tuberculum; 3, 
anterior commissure. F) Projection targets of foxP2 neurons were determined by sparse 
ipsilateral neuron labeling (arrow) using co-injection of plasmids carrying UAS:lyn-
TagRFP and foxP2-enhancerA.2:Gal4 at the one-cell stage, stained for a-RFP.  foxP2 








the caudal diencephalon; and axons that cross directly in the anterior commissure onto 
neurons in the contralateral telencephalon (Figure 4.1E-F). 
 To test the effects of 5-HT on axon pathfinding, we tried a variety of 
pharmacological manipulations of 5-HT signaling.  Embryos were dechorionated and 
incubated with different compounds from 24 to 72 hpf during the critical period for 
foxP2-enhancerA.2 axon pathfinding. The nonspecific 5-HT receptor antagonist 
methysergide (Silberstein, 1998) caused defects in midline crossing of the TCPTc, but 
overall health of the embryos was compromised and it was unclear if the pathfinding 
errors were a secondary nonspecific effect. When we incubated embryos with the 5-HT 
receptor type 2 (hydroxytryptamine receptor 2, htr2) antagonist ketanserin (Brogden 
and Sorkin, 1990), there was no effect on overall mortality or development of the 
embryos. However, Tg(foxP2-enhancerA.2:egfp-caax) embryos treated with ketanserin 
had failure to form the TCPTc, or a reduction in the number of TCPTc axons crossing 
the midline (Figure 4.2A, B).   
 The effects of ketanserin were dose-dependent: levels of 200 mM had minimal 
effect on TCTPc pathfinding (data not shown), and 500 mM was used for experiments. 
We did not observe any overall difference in apoptosis in control compared to 
ketanserin-treated embryos (Figure 4.2C). Further, the reduction in crossing axons was 
not due to a loss of foxP2 neurons, as control and ketanserin-treated embryos had the 
same number of telencephalic neurons (Figure 4.2C). We noted that the defects in axon 
guidance persisted at 5 dpf (days post-fertilization), indicating that the pathfinding 
errors were not due to a developmental delay.  




Figure 4.2.  Commissural axon projections of TCPT neurons are disrupted by blockade 
of 5-HT signaling. (A, B) Tg(foxP2-enhancerA.2:egfp-caax) embryos, maximum 
intensity z-stack projections, a-GFP immunohistochemistry, rostral top, scale bar, 50 
µm. TCPTc midline axon crossing is disrupted (arrow) when treated with ketanserin (B) 
compared to control (A). C) Ketanserin does not cause increased apoptosis in treated 
embryos or changes in overall cell counts in the telencephalon (TUNEL and TOPRO-3 
staining). n = 5 each group. Error bars, standard deviation (apoptosis); standard error of 
the mean (cell counts). D)  Confocal image of Tg(foxP2-enhancerA.2:egfp-caax) embryo, 
showing where measurements were made for the intensity of commissural (C), pre-
crossing longitudinal (L1), and post-crossing (L2) axon tracts (see Methods for details).  
E-G) Scatterplots of results from individual embryos, showing the distribution of C/L 
results.  n=11 and 14, respectively in control and ketanserin-treated group. *, p < 0.05, **, 
p < 0.01; Student’s t-test. Error bars, SEM. E, F) Results of ketanserin-treated compared 
to control axon pathways, showing that in treated embryos the C/L ratio was decreased, 
indicating fewer TCPTc axons crossing the midline.  G) No change was seen in the 
L2/L1 ratios between control and ketanserin-treated embryos, indicating that the 
misguided axons did not preferentially choose the longitudinal tract. H) Intensity ratio 
data shown with values normalized to that in controls.  
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intensity ratios of commissure to longitudinal axons (C/L ratios, Stevenson et al., 
2012). Effects of ketanserin on the TCPTc ranged from minimal to complete loss of the 
TCPTc, and varied from embryo to embryo. We measured the signal intensity of the 
commissure axons, compared to the precommissure longitudinal tract axons (C/L1 
ratio), and to the postcommissure longitudinal tract axons (C/L2 ratio) (Figure 4.2D-F). 
A lower C/L ratio indicates fewer TCPTc axons crossing the midline. Finally, we also 
compared the intensity of the precommissure longitudinal tract, to the postcommissure 
longitudinal tract, in control and ketanserin-treated embryos (L2/L1 ratio, Figure 4.2G). 
We reasoned that if axons in ketanserin-treated embryos were indeed aberrantly 
selecting the longitudinal pathway in preference to the TCPTc, we would see an 
increase of L2/L1 in treated embryos. To address this we examined individual embryo 
raw data ratios, shown as scatterplots (Figure 4.2E-G); as well as normalized ratios 
(Figure 4.2H).  We found that embryos treated with ketanserin had both decreased 
C/L1 and C/L2 ratios (Figure 4.2E, F), consistent with the decrease in axons crossing 
the TCPTc. Additionally, in ketanserin-treated embryos, the L2/L1 ratio did not change 
(Figure 4.2G), suggesting that axons did not select the L2 longitudinal tract 
preferentially. 
   
5-HT receptors are necessary for commissural axon crossing 
 Since we noted the effect of blocking 5-HT signaling, and in particular of the 
htr2 antagonist ketanserin on midline axon crossing, we next determined which htr2 
receptors were expressed in foxP2 neurons. More than 14 different 5-HT receptors are 
expressed in the vertebrate CNS (Barnes and Sharp, 1999). Ketanserin has high affinity 
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for serotonin type 2A receptors but can also bind with lower affinity to type 2C 
receptors (Saxena, 1995). Expression of htr2aa, htr2ab, and htr2c in the 48 hpf 
zebrafish CNS exhibit a spatial overlap in the telencephalon with foxP2 neurons 
(Schneider et al., 2012). We used sections of Tg(foxP2-enhancerA.2:egfp-caax) 
embryos to perform double staining with immunohistochemistry for GFP, and in situ 
hybridization for either htr2aa, htr2ab, or htr2c. We found that all three receptors were 
co-expressed in foxP2 neurons, as well as in foxP2 axons as they extend caudally to 
form the TCPTc.  As explained below, we focused analysis on htr2ab (Figure 4.3A-
B”).    
 To demonstrate the necessity of htr2 for TCPTc axon guidance, and to 
determine which receptor subtype(s) were involved, we used morpholino knockdown of 
the different htr2 receptors alone and in combination. Knock-down of htr2aa or htr2c 
did not affect the TPCTc (Figure 4.3F, G). However, knock-down of htr2ab led to a 
reduction in the C/L1 ratio of the TCPTc, suggesting that 5-HT signaling via htr2ab 
receptors is critical for axon midline crossing (Figure 4.3C, E). Since there was still 
some crossing of the TCPTc, we tried co-injection of htr2ab and htr2aa morpholinos.  
This caused disruption of embryogenesis and severe dysmorphism of the body axis, 
preventing analysis of pathfinding.  
            To confirm specificity of the htr2ab morpholino phenotype, we designed and used 
CRISPR/Cas9 gene disruption of htr2ab (Figure 4.3D). Injection of CRISPR/Cas9 can 
lead to high-frequency bi-allelic disruption of the targeted gene in somatic cells (Jao et 
al., 2013; Jinek et al., 2012). We co-injected Cas9 protein and an htr2ab short guide RNA 










Figure 4.3. htr2ab is necessary for TCPTc formation. A-B”, sections of 48hpf Tg(foxP2-
enhancerA.2:egfp-caax) embryo, double-labeled for htr2ab in situ and a-GFP, rostral top, 
scale bar 50 mm.  Bright field (A), fluorescent (A’), and merged images (A”) show 
htr2ab expression in foxP2 neurons and in axon tracts. B-B”) shows higher magnification 
of boxed region in A”. C) htr2ab splice-blocking morpholino targets exon 1/intron 1 
boundary. Gel shows that morpholino partially blocks normal splicing (arrowhead). D) 
Schematic of htr2ab sgRNA used in CRISPR experiments.  E)  htr2ab knock-down 
causes decreased TCPTc midline axon crossing. C/L1 normalized ratio data of TCPTc 
crossing. htr2ab morpholino or sgRNA/Cas9 -injected embryos have lower C/L1 ratios, 
indicating failure of midline axon crossing. C/L1 ratio is rescued in embryos co-injected 
with htr2ab mRNA and sgRNA/Cas9. (n=11, 14, 10, 9, 11, respectively in columns. * p 
< 0.05, ** p < 0.01; Student’s t-test for morpholino; one-way ANOVA with Turkey’s 
post-hoc test for CRISPR.  Error bars, SEM.)  (F) Scatterplot of C/L1 ratios shows that 
morpholino mediated knockdown of htr2aa and htr2ac does not affect axon pathfinding. 
(G) Normalized C/L1 ratios in htr2aa and htr2c morpholino-injected embryos.  H) High 
Resolution Melting Analysis (HRMA) (Xing et al., 2014) of PCR products shows that 36 
out of 38 embryos injected with htr2ab sgRNA/Cas9 have an abnormal melt-curve 
indicating a mutation. I) Proportion of in-frame and out-of-frame mutations, sequenced 
from htr2ab PCR amplicons for two embryos (all PCR products had mutations). J) 
Sequences from cloned PCR amplicons from htr2ab CRISPR.  The target site and 
protospacer adjacent motif (PAM) are highlighted in grey and blue, respectively. 
Representative sequences of htr2ab mutations in the F0 are shown. Insertions, deletions 








the F0 embryos (n= 36/38 injected embryos) (Figure 4.3H-J). To validate the extent of 
mutagenesis, we cloned 18 individual PCR amplicons each from two F0 embryos. Sanger 
sequencing showed that all 36 PCR products had mutations (deletions or insertions); 
27/36 amplicons were outofframe and would cause a stop or an early protein truncation. 
The remaining 9 in-frame mutations caused a variety of short amino acid insertions or 
deletions.   
 We injected Tg(foxP2-enhancerA.2:egfp-caax) embryos with htr2ab 
CRISPR/Cas9 sgRNA; we found that F0 injected embryos had failure of TCPTc 
commissure formation, with a decreased C/L1 ratio (Figure 4.3E). The TCPTc formation 
defects induced by CRISPR/Cas9 sgRNA were rescued when co-injected with htr2ab 
mRNA (Figure 4.3E), indicating the specificity of CRISPR/Cas9 sgRNA. We validated 
that the CRISPR was still functional in the co-injected embryos by PCR analysis at the 
endogenous htr2ab locus, indicating that the rescue was due to the htr2ab mRNA, not 
due to failure of mutagenesis induced by CRISPR/Cas9 sgRNA.  Thus, loss of htr2ab, 
either by morpholino knock-down or CRISPR gene disruption, leads to midline crossing 
errors in the TCPTc, supporting a role for 5-HT signaling in the TCPT axons as they 
decussate. 
 
Raphe neuron serotonin expression is necessary for commissure formation 
 Since our data suggested a role for the htr2ab receptor and 5-HT signaling in 
midline crossing of TCPTc axons, we next tested if a source of 5-HT was available to the 
TCPTc axon growth cones during development.  In zebrafish the dorsal raphe nucleus 
expresses 5-HT by 36 hpf and 5-HT axonal projections are widely distributed in the CNS 
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by 72 hpf (Lillesaar et al., 2009). To determine whether TCPTc axons encountered a 5-
HT source, we performed immunostaining for 5-HT and for GFP in Tg(foxP2-
enhancerA.2:egfp-caax) embryos. We found that serotonin-expressing neurons had 
projections neighboring the ends of TCPTc axons prior to their midline crossing (Figure 
4.4A-A”). We confirmed this in confocal single slice high-resolution images (Figure 
4.4B-B”, C-E).  
 In zebrafish, unlike mammals, several 5-HT nuclei are present in the CNS 
(Kaslin and Panula, 2001, McLean and Fetcho, 2004; Lillesaar, 2011), including 
pretectal and posterior tuberculum/hypothalamic nuclei (Figure 4.4A’, arrowhead). To 
determine whether the raphe nuclei were the source of the serotonergic projections for 
the TCPTc axons, we used an enhancer for 5-HT neurons specific to the raphe nucleus, 
-3.2pet1 (referred to as “pet1”) (Lillesaar et al., 2009). We examined axon projections 
from the raphe 5-HT neurons to the TCPTc axons in triple-transgenic animals: 
Tg(pet1:Gal4); Tg(UAS:RFP-caax); Tg(foxP2-enhancerA.2:egfp-caax). We observed 
RFP-expressing axons from the raphe nuclei projecting to the TCPTc axons (Figure 
4.4F-I), including in single slice confocal images, confirming that the raphe neurons are 
the likely source of 5-HT for TCPTc axons. 
 To determine whether the raphe neurons are necessary to provide 5-HT for 
TCPTc midline crossing, we performed targeted genetic ablation of the raphe. We used 
the cell-autonomous nitroreductase/metronidazole system (Curado et al., 2008; 
Pisharath and Parsons, 2009), driving expression of nitroreductase (Tg(UAS:NTR-
mCherry)) in raphe 5-HT neurons using Tg(tph2:Gal4) (Yokogawa et al., 2012); and 
















Figure 4.4.  Serotonergic neurons project in close apposition to TCPTc commissural 
axon tips prior to midline crossing. A-B”) Confocal images of whole-mount embryo at 48 
hpf, rostral top, scale bar 50 µm. Tg(foxP2-enhancerA.2:egfp-caax) embryo double-
labeled for a-GFP and for a-5-HT. Boxed region in A” is shown at higher resolution in B-
B”, as single confocal slice.  Arrow points to serotonin-expressing axon projections (red) 
overlapping foxP2 TCPTc developing axons (green). C-E) XZ and YZ plane projections 
from consecutive confocal slices confirm the overlap between 5-HT axons and TCPTc 
growth cones. F-G”) Confocal images of Tg(foxP2-enhancerA.2:egfp-caax); 
Tg(pet1:Gal4); Tg(UAS:RFP-caax) whole-mount embryo at 56hpf, rostral top, scale bar 
50 mm, double immunohistochemistry for a-GFP and a-RFP, demonstrating that the 
raphe nucleus axons could provide 5-HT for foxP2 axons. Boxed region in F’ is shown in 
higher resolution G-G” as single confocal slice. Arrows (G) point to RFP expression from 





















Figure 4.5. Ablation of the 5-HT neurons causes TCPTc midline crossing defects. A) 
Schematic diagram of nitroreductase (NTR)/metronidazole (Mtz) experiments. tph2:Gal4 
embryos treated with Mtz from 0-96hpf; in double-transgenic animals (tph2:Gal4; 
UAS:NTR-mCherry), Mtz is converted to a toxic metabolite causing apoptosis of 5-
HT/tph2 neurons.  B-G) Confocal images of whole-mount embryo at 96 hpf, rostral top, 
scale bar 50 µm. B) Embryos without Mtz treatment. C) Mtz treatment leads to axon 
crossing defects in embryos expressing tph2:Gal4/UAS:NTR-mCherry. D, F) Embryos 
without Mtz treatment, immunohistochemistry for mCherry (D) or 5-HT (F). E, G) 
Embryos expressing tph2:Gal4/UAS:NTR-mCherry treated with Mtz, 
immunohistochemistry for mCherry (E) or 5-HT (G). H) Normalized C/L1 ratios show 
that ablation of raphe nuclei leads to the failure of TCPTc axon crossing. (n  = 6, 8, 10, 
respectively in columns. ** p < 0.01, *** p < 0.001, one-way ANOVA with Turkey’s 







We used the Tg(tph2:Gal4) line because we noted that Tg(pet1:Gal4) expressed in 
fewer 5-HT raphe neurons. In the absence of metronidazole, there was no ablation of 
raphe neurons and TCPTc axon pathfinding was normal (Figure 4.5B, D, F). With 
addition of metronidazole, ablation of raphe neurons occurred in embryos expressing 
nitroreductase, with loss of 5-HT and disruption of TCPTc midline crossing (Figure 
4.5C, E, G). In embryos with no nitroreductase, metronidazole had no significant effect 
on midline axon crossing or on the number of 5-HT neurons. These results show that 5-
HT is necessary for TCPTc midline crossing, and demonstrate that the raphe nucleus is 
the likely source of 5-HT. 
 
ephrinB2a limits midline crossing and mediates 5-HT action on pathfinding 
 We had previously shown that the transmembrane ligand ephrinB2a is involved 
in TCPTc axon midline crossing, and that its ligand ephA4a is expressed in a 
complementary pattern to the TCPT axons in the CNS midline (Stevenson et al., 2012).  
The ephrinB family of ligands are known to be involved in midline commissure 
formation (Imondi and Kaprielian, 2001;  Kadison et al., 2006). To test whether 5-HT’s 
role in TCPTc midline axon guidance could be mediated by ephrinB2a, we obtained 
and characterized an ephrinB2a mutant allele, efnB2ahu3393 from the Zebrafish Mutation 
Project (Wellcome Trust Sanger Institute; (Kettleborough et al., 2013). efnB2ahu3393 is a 
nonsense mutation in exon 2 of ephrinB2a (T>A; C86X) (Figure 4.6A). efnB2ahu3393 
homozygotes (“efnB2a-/-“) are viable, and immunohistochemistry demonstrates loss of 
ephrinB2a protein (Figure 4.6B, C). Tubulin staining of homozygous mutants did not 















Figure 4.6. 5-HT mediates axon guidance through ephrinB2a (efnB2a).  A)  The 
efnB2ahu3393 allele is a nonsense mutation in the receptor-binding domain (exon 2) of 
ephrinB2a (T>A; C86X). SP, signal peptide. RBD, receptor-binding domain. TM, 
transmembrane domain. B-K, M, M’) Confocal images, rostral top, scale bar 50 µm. B, 
C) efnB2 immunohistochemistry. efnB2 protein is absent in efnB2ahu3393/hu3393 (efnB2a-/-) 
embryo compared to WT. D-G) Acetylated tubulin immunohistochemistry does not show 
gross axon defects in efnB2a-/- embryos. D, E) Axons in dorsal brain. F, G) Axons in 
ventral brain. H-K) GFP immunohistochemistry in Tg(foxP2-enhancerA.2:egfp-caax) 
embryos shows that lack of efnB2 (in efnB2a-/- embryos, J, K) prevents ketanserin-
induced midline crossing defects (arrow) compared to efnB2a heterozygotes (H, I).  L) 
Quantification confirms that efnB2a-/- restores axon guidance in presence of ketanserin. (n 
= 10 per group. * p < 0.05, two-way ANOVA followed by Bonferroni post-test. Error 








appeared normal on visual inspection in the homozygous efnB2a-/- background (Figure 
4.6J), but there was a statistically significant increase in the number of crossing axons 
(Figure 4.6L).  
 Blockade of 5-HT signaling in efnB2a+/- heterozygotes by ketanserin causes 
TCPTc axon pathfinding defects similar to that seen in a wild-type background (Figure 
4.6H, I, L). However, in efnB2a-/-  homozygous mutants treated with ketanserin, TCPTc 
midline axon crossing was normal (Figure 4.6J-L). efnB2a-/- mutants do not have a 
change in raphe 5-HT expression (Figure 4.6M, M’). These results show a role for 
ephrinB2a in normally limiting midline axon crossing, and in mediating the action of 5-
HT on the TCPTc decussation. 
 
5-HT regulates ephrinB2a translation in the axon 
 How does 5-HT signaling interact with ephrinB2a regulation of TCPTc midline 
axon crossing? Axon guidance molecule expression can be regulated or modified by 
transcription, translation, or posttranslational processes (Winckler and Mellman, 2010; 
Jung et al., 2011; Hancock et al., 2014). 5-HT is able to stimulate translation in 
subcellular domains of target cells (Martin et al., 1997; Casadio et al., 1999; Miniaci et 
al., 2008). This could be a possible mechanism by which it could regulate axon 
guidance receptor activity.  
 To address these potential mechanisms, we examined levels of ephrinB2a in 
ketanserin-treated embryos. We found no significant difference in overall ephrinB2a 
RNA transcript levels by RT-PCR in whole embryos. However, after ketanserin 
treatment we noted increased ephrinB2a protein levels in embryos by quantification of 
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immunofluorescence levels, including in the telencephalon and TCPTc axons (Figure 
4.7A-C), but not in the eyes. To demonstrate that ketanserin’s effect on ephrinB2a 
levels was dependent on 5-HT, we performed ablation of raphe 5-HT neurons in 
Tg(tph2:Gal4); Tg(UAS:NTR-mCherry) embryos. We found that raphe neuron ablation 
led to an increase of ephrinB2a protein levels in the TCPTc axons, but not in the 
telencephalon and eyes (Figure 4.7D-G).  
 
5-HT responds to hypoxia to decrease midline axon crossing 
Since 5-HT has demonstrated roles in mediating adult plasticity, we considered 
whether 5-HT might also have a role in regulating axon guidance in response to 
environmental or developmental factors.  Interpretation of external factors and changes to 
developing circuitry would be a mechanism by which a developing organism could 
modify its regulation of connectivity. Previous work from our lab demonstrated that 
hypoxia disrupts midline axon crossing by increasing levels of ephrinB2a (Stevenson et 
al., 2012). In nematodes hypoxia increases 5-HT expression, with a resultant activation of 
a latent sensory circuit (Pocock and Hobert, 2010). To test if hypoxia affects 5-HT 
expression we exposed developing zebrafish embryos to hypoxia from 24 to 36 hpf 
(Stevenson et al., 2012), and examined levels of 5-HT at 72 hpf. We found a decrease in 
5-HT levels at 72 hpf (Figure 4.8A-D) but normal cell counts in the raphe. Hypoxia’s 
effect on 5-HT expression was specific, since there were not effects on apoptosis or 
general embryo viability (Stevenson et al., 2012); and because levels of expression of the 





Figure 4.7. 5-HT regulates ephrinB2a (efnB2a) protein levels.  A, B, E, F) Confocal 
images, 36hpf embryos, immunohistochemistry for a-efnB2a, rostral top, scale bar, 50 
µm. A, B) efnB2a levels are increased in telencephalon (boxed region) and TCPTc axons 
(arrows) in embryos treated with ketanserin (B) compared to control (A). C) 
Quantification of ephB2a levels in telencephalon and TCPTc axons. (n = 20, 14, 
respectively in control and embryos treated with ketanserin. ** p < 0.01, Student’s t-test. 
Error bars, SEM.) D) Schematic illustration of Mtz treatment in NTR- and NTR+ 
embryos. Genotypes in each group shown on right. Note that ablation can occur only 
when both tph2:Gal4 and UAS:NTR-mCherry are expressed. E, F) efnB2a levels in 
TCPTc axons (arrows) are increased but not in the telencephalon (boxed region), in 
embryos expressing tph2:Gal4/UAS:NTR-mCherry (F) compared to embryos without 
NTR expression (E) following treatment with Mtz. G) Quantification of efnB2a levels in 
telencephalon and TCPTc axons. (n = 10, 12, respectively in NTR- and NTR+ embryos. 














Figure 4.8. 5-HT signaling is an interpreter of developmental environment to control 
TCPTc midline crossing. A-B’) Hypoxia decreases 5-HT expression.  Normoxia 
compared to hypoxia, confocal images of WT embryos at 48 hpf, maximal intensity z-
stack projections, stained with 5-HT (A, B), stained with HuC/D (A’, B’), rostral top, 
scale bar, 50 µm. C) 5-HT levels in raphe neurons (normalized to pan-neuronal marker 
HuC/D) are significantly decreased by hypoxia. (n = 6 per group, ** p < 0.01 Student’s t-
test.) D) HuC/D levels are not changed following hypoxia. (n = 6 per group. Error bars, 
SEM). E) Bright field in situ shows that tph2 mRNA is specifically expressed in raphe. F) 
tph2 mRNA levels (qRT-PCR) are decreased in 36 hpf and 48 hpf post-hypoxic embryos. 
(Error bars, SEM, three experimental replicates.) G-H), confocal images of Tg(foxP2-
enhancerA.2:egfp-caax) show that fluoxetine (H) rescues axon guidance defects in 
hypoxic embryos (G). I) Normalized C/L1 ratio data confirms fluoxetine rescue of 
hypoxia effects. (n = 10, 13, 14, respectively in columns. * p < 0.05, ** p < 0.01, one-







Tryptophan hydroxylase (tph) is the rate-limiting enzyme for 5-HT biosynthesis; 
raphe neurons in zebrafish express the Tph ortholog tph2 (Bellipanni et al., 2002;  
Teraoka et al., 2004). tph expression in other species has been shown to be responsive to 
hypoxia (Pocock and Hobert, 2010; Rahman and Thomas, 2009). Using qRT-PCR, we 
found that following hypoxia tph2 RNA expression was decreased in the raphe nucleus. 
The decrease in tph2 was present at 36 hpf, immediately following cessation of hypoxia, 
and persisted at 48 hpf (Figure 4.8E, F).   
Since hypoxia decreased 5-HT levels, we reasoned that rescuing 5-HT signaling 
in hypoxia embryos should prevent midline axon crossing errors. To test this we 
incubated hypoxic embryos with fluoxetine, a selective 5-HT reuptake inhibitor (SSRI), 
which increases available 5-HT at the synapse. We found that fluoxetine incubation from 
24hpf to 72hpf rescued the effect of hypoxia on midline axon crossing (Figure 4.8G-I).  
Hypoxia did not affect the overall distribution of raphe 5-HT axon projections. These 
data show that raphe neurons can respond to environmental hypoxia and modulate 5-HT 
expression, thereby altering neural circuit development. 
 
Discussion 
            We have found that 5-HT and its receptor htr2ab provide instructive guidance for 
midline axon crossing, through down-regulation of ephrinB2a levels. 5-HT’s role is 
sensitive to environmental cues, as developmental hypoxia decreases 5-HT expression 
from the raphe neurons and causes midline crossing defects. Our findings suggest that 
modification of the serotonergic system by early environmental exposures may contribute 
to permanent CNS connectivity alterations.  
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5-HT and htr2ab are necessary for axon guidance 
           The components of 5-HT signaling are conserved over 2 billion years of evolution 
from protozoa to mammals (Azmitia, 2007). During evolution 5-HT’s roles and 
localization of action have become increasingly more specialized. In unicellular 
eukaryotes such as the ciliate protozoa Tetrahymena, 5-HT acts in intracellular signaling; 
in primitive metazoans such as Planaria, 5-HT has additional roles in hormonal cell-cell 
signaling; and in the nervous system of arthropods and vertebrates, 5-HT acts as a 
neurotransmitter at synapses (Hay-Schmidt, 2000; Turlejski, 1996). In mammals 5-HT 
signaling plays important roles in regulating behavior, memory consolidation, sleep, and 
appetite (Gingrich et al., 2003). Abnormalities in the 5-HT system in humans are 
associated with a range of neurobehavioral and neuropsychiatric disorders (Blasi et al., 
2013; Harrington et al., 2013; Lesch and Waider, 2012).   
           Roles for 5-HT in early CNS development have recently been uncovered, 
including in neuron migration, dendrite arborization, and synapse formation (Matsukawa 
et al., 2003; Persico et al., 2001; Riccio et al., 2009; Vitalis et al., 2007). 5-HT signaling 
has been suggested to regulate axon guidance: in mice overexpression of 5-HT receptors 
causes a shift in thalamocortical axon tracts (Bonnin et al., 2007), and rats lacking the 5-
HT transporter had altered raphe-prefrontal cortex pathways (Witteveen et al., 2013). We 
found that 5-HT acting through htr2ab, an excitatory G-protein coupled receptor, is 
necessary for normal midline axon crossing. We confirmed this finding using 
pharmacological blockade of htr2 as well as with both morpholino and CRISPR/Cas9 
knock-down of htr2ab. We found that the source of the 5-HT is from neurons of the 
raphe nucleus, by demonstrating close apposition of 5-HT axon termini to the termini of 
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TCPTc axons. Further, using cell-type specific genetic ablation we demonstrated that the 
raphe neurons are a necessary source of 5-HT TCPTc axon development. However, we 
cannot fully exclude the involvement of other 5-HT sources as well, for example the cell 
cluster located medially and anterior to the paraventricular organ (Lillesaar, 2009).   
ephrinB2a mediates serotonin-associated axon pathfinding 
           ephrinB2 acts as a ligand for receptor tyrosine kinases (RTK) of the EphA and 
EphB families, inducing an intracellular signaling cascade in the RTK-expressing cell 
(Bashaw and Klein, 2010). EphrinB ligands are also known to “reverse” signal (Pasquale, 
2008; Taylor et al., 2012), which we observed in previous studies on TCPTc pathfinding 
in the setting of hypoxia (Stevenson et al., 2012). Several studies have demonstrated that 
ephrinB signaling can function in midline crossing. For example, in Xenopus, ephrinB 
regulates ipsilateral sorting of retinal axons at the midline optic chiasm (Nakagawa et al., 
2003); in chick, ephB2 expression at the midline repels axons at older ages (Cramer et al., 
2006).  
 We found that pharmacological blockade of serotonergic signaling through its G-
protein coupled receptor (GPCR) htr2a, or ablation of the raphe 5-HT neurons, increased 
ephrinB2a protein levels in the TCPTc axons. This increase in ephrinB2a could be due to 
increased transcription: both GPCRs and transcription factors including Tbx5 and VAX2 
have been shown to alter ephrinB transcription levels (Jassen et al., 2006; Polleux et al., 
2007). However, when we measured ephrinB2a mRNA levels using qRT-PCR we did not 
observe changes in embryos treated with htr2a antagonist; though we cannot exclude the 
possibility that local or subtle changes in ephrinB2a transcript levels are masked. Thus, 
our data support a role for 5-HT regulation of ephrinB2a protein levels. This could be by 
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increased translation of ephrinB2a, or by regulation of stability of ephrinB2a. Studies in 
Aplysia neuron cultures show that 5-HT can stimulate translation in subcellular domains 
of target cells (Casadio et al., 1999; Martin et al., 1997; Miniaci et al., 2008). This effect 
on translation could be through second messenger systems such as CPEB or CREB as in 
Aplysia; or alternatively 5-HT might exert its effect through miRNAs. ephrinB2 can be 
regulated by multiple miRNAs (Wang et al., 2012), and drugs modifying the serotonergic 
system can alter miRNA expression (Baudry et al., 2010). miRNAs are present in axon 
growth cones and can alter local translation (Kaplan et al., 2013). Future studies could 
examine the interaction between serotonin signaling during development and effects on 
local translation and axon guidance. 
 
Role of the raphe nucleus and serotonin in embryonic development 
  We observed that hypoxia disrupts axon connectivity by decreasing 5-HT 
synthesis. If serotonergic signaling is increased by blockade of 5-HT reuptake, then the 
effects of hypoxia on TCPTc midline crossing are prevented. Thus the raphe nucleus, 
through regulation of 5-HT levels, which in turn affects midline axon guidance, 
effectively act as a sensor to changes in the embryonic milieu. Interestingly, in the adult 
rat dorsal raphe 5-HT neurons also respond to the environment, acting as chemoreceptors 
to changes in blood pH/CO2 levels with altered firing patterns (Severson et al., 2003).   
 5-HT axon projections are widespread in early development during the period 
when extensive axon pathfinding is occurring (Lillesaar et al., 2009; Rubenstein, 1998); 
exposures to serotonergic drugs during gestation have been linked with increased risks 
for neurodevelopmental disorders (El Marroun et al., 2014; Gidaya et al., 2014; 
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Harrington et al., 2014; Rai et al., 2013); and polymorphisms in genes in the 5-HT 
signaling pathway are associated with a range of neuropsychiatric disorders (Kuzelova et 
al., 2010; Prasad et al., 2009; Sutcliffe et al., 2005). Loss or knock-out in early 
development of 5-HT neurons or other components of 5-HT signaling leads to diffuse 
CNS abnormalities with a wide range of behavioral phenotypes (Daubert and Condron, 
2010; van Kleef et al., 2012). In the invertebrate C. elegans hypoxia can increase 5-HT 
expression and change a neural circuit response to gustatory sensation (Pocock and 
Hobert, 2010), providing evidence of biological relevance for an interaction between 5-
HT signaling and neural circuits. These lines of evidence, in addition to the work 
presented here, are consistent with 5-HT acting to mediate changes in how connectivity 
develops. Future studies can examine the evolutionary and neurobiology significance of 
5-HT’s role for axon guidance, and its responsiveness to external conditions during 
development.   
 
Conclusion 
 The findings here suggest a model in which serotonergic signaling, supplied by 
embryonic axon projections from the raphe nucleus, is necessary for normal midline axon 
crossing (Figure 4.9).  In the presence of 5-HT, levels of ephrinB2a are decreased and 
axons are able to cross the midline. Conversely, if 5-HT levels are decreased, by 
pharmacological manipulation or through hypoxic exposure, ephrinB2a levels are higher 
(our data and Stevenson et al., 2012), and axons fail to cross the midline or take abnormal 
paths. Regulation of midline crossing is complex and includes interacting attractive and  













Figure 4.9.  Model. A) During development, TCPTc growth cones are exposed to 5-HT 
from raphe nuclei axon projections. 5-HT activates htr2ab in the TCPTc, decreasing 
expression of ephrinB2a, and allowing axons to cross the midline. B) When 5-HT 
signaling is inhibited by drug, knockdown, or hypoxia, the up-regulation of ephrinB2a 








unexpectedly more complex systems of axon guidance, including of balancing neuronal 
 
activity, although it is not clear if this applies to midline crossing (Suarez et al., 2014).  
 Our data show a novel link between the embryonic environment and early circuit 
formation. We provide evidence that 5-HT is instructive for CNS axon guidance and that 
5-HT circuits regulate connectivity development. Our findings suggest that modification 
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The work in this dissertation has advanced understanding of the molecular 
mechanisms involved in axon development. I developed a zebrafish developmental 
model to investigate the role of 5-HT and FoxP2 in axon guidance. I found that FoxP2 is 
not necessary for axon pathfinding in the defined axon TCPTc (Figure 5.1A) (see Chapter 
3) (Figure 5.1B), but it can increase the expression levels of CNTNAP2. I also discovered 
that 5-HT is required for TCPTc axon guidance by inhibiting the protein levels of 
ephrinB2a  (see Chapter 4) (Figure 5.1C).  
In Chapter 2, I also show that PCR combined with high resolution melting 
analysis (HRMA) is a rapid and powerful technique for genotyping. HRMA can detect 
single point mutations, and is ideal for large-scale screening. It can be used in both 
embryonic and adult zebrafish to detect transgenes as well as mutations induced either by 
zinc finger nucleases (ZFNs), transcription activation-like effector nucleases (TALENs) 
or clustered regularly interspaced short palindromic repeats (CRISPR) (Dahlem et al. 
2012; Parant et al. 2009; Xing et al. 2012; Xing, unpublished). Application of HRMA 






Figure 5.1. Model of regulation mechanisms involved in TCPTc formation. A. 
Illustration of  TCPTc pathways in 72 hpf zebrafish. B. FoxP2 increases expression of 
CNTNAP2, but is not required for TCPTc formation (Chapter 3). C. 5-HT inhibits 
ephrinB2a protein levels and contributes to TCPTc formation (Chapter 4).  
 
The role of FoxP2 in development 
            When the study was initiated, very little was known about the mechanism by 
which FoxP2 regulates early brain development. Though studies in multiple species, 
including human, mouse, and songbird, indicate that FoxP2 is necessary for brain 
development (Groszer et al., 2008; Haesler et al., 2004; Lai et al., 2001; Shu et al., 2005; 
Takahashi et al., 2003; Vargha-Khadem et al., 2005), only one single study tested the 
direct role of FoxP2 in development.  This study identified FoxP2 as necessary for 
neurite outgrowth by a cell culture assay (Vernes et al., 2011). Our study finds that knock 
down of FoxP2 leads to a decreased expression level of CNTNAP2. Combined with the 
recent findings that FoxP2 is involved in neuronal differentiation and neurogenesis 
during development (Devanna et al., 2014; Tsui et al., 2013), our study suggests that 
FoxP2 plays a complex role in brain development, which might be mediated by a variety 
of downstream target signaling. The multiple developmental roles of FoxP2 thus might 
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account for the importance of FoxP2 in language development and processing. 
A few studies have indicated that FoxP2 might be involved in axon development, 
since FoxP2 can target multiple axon guidance molecules, including EPHA2 and 
SEMA3B (Spiteri et al., 2007; Vernes et al., 2007, 2011). However, in axon tracts I 
identified in zebrafish, including the TCPTc and dopaminergic axons, I did not observe 
axon guidance defects in FoxP2 mutants. Though I did not find abnormal axon 
pathfinding in FoxP2 mutants, I cannot exclude the possibility that FoxP2 might exert 
subtle effects on axon pathfinding that our assays could not detect, nor the possibility that 
FoxP2 plays a role in other unidentified axon tracts. We can take advantage of multiple 
transgenic lines having been generated in zebrafish to address the general role of FoxP2 
in the CNS axons. Studies are also required in order to test whether FoxP2 plays a 
conserved role in axon guidance among different species. The FoxP2 protein is highly 
conserved in mammals. In chimpanzees, FoxP2 differs from that in humans by the 
substitution of two amino acids (Enard et al., 2002). It is proposed that the two amino 
acid substitutions are critical for language and speech development in humans. 
Consequently, dissecting the developmental role of FoxP2 among different species will 
provide insight into the functional changes of FoxP2 during evolution. On the other hand, 
we should be cautious to interpret the novel function of FoxP2 in humans, since FoxP2 is 
also important for imitation of tutor songs in songbirds and appropriate ultrasonic 
vocalization in mice (Haesler et al., 2004; Shu et al., 2005; Teramitsu et al., 2004). The 
uniquely expressive power of human language must derive from the delicate interaction 
between FoxP2 and numerous other molecules, rather than from the role of the single 
molecule FoxP2.  
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Given our findings of decreased CNTNAP2 expression levels in FoxP2 mutants, 
and the role of CNTNAP2 in synaptic function (Groszer et al., 2008; Spiteri et al., 2007; 
Vernes et al., 2007), future studies will be needed to examine the role of FoxP2 in 
synaptic development. To elucidate the role of FoxP2 in synaptic development, numerous 
novel techniques can be employed. These include: GFP reconstitution across synaptic 
partners (GRASP), Fibronectin intrabodies generated with mRNA display (FingR), 
genetically encoded fluorescent synaptic proteins such as SYP (synaptophysin)-EGFP or 
Trans-Cellular Activation of Transcription (TCAT), currently being developed in our 
laboratory (Appelbaum et al., 2010; Bonkowsky et al., unpublished; Gross et al., 2013; 
Kim et al., 2012). These techniques provide a powerful means to visualize endogenous 
synapses in live zebrafish, and thus will promote our understanding of molecular 
mechanisms (including FoxP2) involved in synaptic formation and function. Elucidating 
the role of FoxP2 in axon guidance and/or synaptic formation will help us better 
understand the mechanism by which FoxP2 regulates early brain wiring and interpret 
how disruption of FoxP2 contributes to specific language impairment.  
 
The role of 5-HT in axon development 
I have shown that 5-HT is necessary for TCPTc formation with an in vivo system. 
This adds another piece of evidence that 5-HT is important for early brain development. 
Many studies have shown that the role of the neurotransmitter 5-HT is to function in 
adult physiology by modulation of synaptic strength (Gingrich et al., 2003; Lesch and 
Waider, 2012). However, more and more evidence demonstrates that 5-HT is involved in 
brain circuit formation by regulating neuronal migration, synapse formation, axonal 
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branching, and dendrite arborization (Matsukawa et al., 2003; Persico et al., 2001; Riccio 
et al., 2009; Vitalis et al., 2007). The critical role of 5-HT in early development may 
account for clinical outcomes in children exposed to prenatal selective serotonin reuptake 
inhibitors (SSRIs). Prenatal use of SSRIs have been found to result in susceptibility to 
autism or other developmental delays, particularly in boys (Harrington et al., 2014). 
Elucidating the role of 5-HT in early brain circuit formation will advance our knowledge 
of pathogenic mechanisms in many neurological disorders. However, to date, very few 
studies are available to examine the direct mechanism of 5-HT involved in development.  
We found that 5-HT controls axon pathfinding through the regulation of the axon 
guidance receptor ephrinB2a. In the presence of 5-HT, levels of ephrinB2a are decreased, 
and axons are able to cross the midline. Conversely, when serotonergic signaling is 
decreased, by pharmacological manipulation or ablation of serotonergic neurons, 
ephrinB2a levels are increased and axons fail to cross the midline. We interpret this 
finding to mean that 5-HT regulates the protein levels of an axon guidance receptor, 
ephrinB2a, revealing a novel mechanism by which a monoamine is involved in 
development. Further studies will determine how 5-HT regulates ephrinB2a protein 
levels in axons. The regulation of axon guidance receptors by either protein synthesis or 
transport are important mechanisms in axon guidance (Dent and Gertler, 2003; Jung et 
al., 2012; Martin, 2004); these mechanisms are candidates for the regulation of ephrinB2a 
by 5-HT. Dissecting the mechanism by which 5-HT regulates axon guidance receptors 
will facilitate progress in understanding the role of 5-HT in early development and later 
behavior.  
We found that in zebrafish 5-HT regulates axon guidance via 5-HTR2, distinct 
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from what has been observed in mice, in which 5-HT modulation of axon guidance is 
mediated by 5-HT1B/1D (Bonnin et al., 2007). This indicates that both excitatory (5-
HTR2) and inhibitory (5-HTR1) receptors can be activated by 5-HT during development, 
adding to the complexity of networks regulated by 5-HT. HTR2 is a G-protein coupled 
receptor that activates phospholipase C and then catalyzes the conversion of 
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and di-
glyceride (DAG). IP3 acts on a ligand-gated Ca2+ channel, resulting in the release of Ca2+ 
from the endoplasmic reticulum into the cytoplasm.  I hypothesized that activation of this 
signaling pathway results in a decrease in ephrinB2a levels. However, when I tested the 
effect of Ca2+ release on ephrinB2a levels by inhibiting Ca2+ release from the intracellular 
sarcoplasmic reticulum with u73122 or 2-Aminoethoxydiphenyl borate, I did not observe 
altered ephrinB2 levels (data not shown). This indicates that 5-HT acts via a nonclassical 
pathway during axon guidance, suggesting that 5-HT plays an instructive role, not a 
modulatory role in midline axon crossing, in contrast to what has been found in mice 
(Bonnin et al., 2007). Bonnin’s study showed that the second messenger cAMP mediates 
5-HT modulation of axonal response to netrin-1. The distinct mechanisms found in mice 
and zebrafish show the diversity of 5-HT response during axon pathfinding. Future 
studies will determine how 5-HT interacts with the molecule ephrinB2a.  
In the future, it will be of particular interest to expand this study to characterize 
the general role of 5-HT in the development of a variety of CNS axons. To achieve that, 
we can utilize multiple transgenic zebrafish lines generated in the lab to test whether the 
modification of serotonergic signaling leads to other axon guidance defects in the 
developing CNS. This will result in a better understanding of the role of 5-HT in brain 
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wiring. Based on the fact that deficiency of 5-HT synthesis by tph2 knock out does not 
lead to gross cellular or morphological changes in brain architecture (Narboux-Nême et 
al., 2013), I expect a specific role for 5-HT will be found in only certain brain circuits. 
This specific role of 5-HT might be due to the spatial and temporal regulation of 5-HT in 
the CNS development. 
 
The regulation of axon guidance by 5-HT under hypoxia 
We found that a decreased level of 5-HT by hypoxia contributes to axon guidance 
defects. The finding suggests that modification of the serotonergic system by early 
environmental exposures contributes to permanent CNS connectivity alterations. 
Alteration of serotonergic signaling has been observed in many neurological disorders, 
such as autism, mental retardation, and depression (Berger-Sweeney and Hohmann, 
1997), consistent with the potential role of 5-HT in early brain circuit formation 
(Matsukawa et al., 2003; Persico et al., 2001; Riccio et al., 2009; Vitalis et al., 2007). Our 
finding suggests that 5-HT could be a mediator, translating the environmental stimuli into 
neural circuit changes. This might explain the plasticity of the serotonergic system in 
response to the environment. 
I discovered a novel neural circuit modified by 5-HT under hypoxic conditions. 
The axon guidance defects that I have observed under hypoxic conditions suggest that the 
developmental environment can manipulate neural circuits. Interestingly, the axon 
guidance defects in hypoxic zebrafish embryos recapitulate the phenotype observed in 
some premature infants by diffusion tensor imaging (DTI) (Yeatman et al., 2009), which 
indicates that the conserved circuits and/or pathways are affected by environmental stress. 
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Fluoxetine, a serotonin reuptake inhibitor, rescued axon guidance defects following 
hypoxia in our experiment. This indicates that early intervention is an efficient way to 
minimize brain abnormalities. Therefore, elucidating the role of 5-HT or other molecules 
in zebrafish development will help us understand the occurrence of neurodevelopmental 
disorders correlated to an adverse environment or a modified serotonergic system.  
 
Conclusion 
In this dissertation, I have shown the value of the HRMA technique for large-
scale genotyping, and have examined the effects of FoxP2 and 5-HT in the developing 
zebrafish brain. PCR combined with HRMA promotes identification and characterization 
of genes involved in zebrafish brain development. FoxP2 can regulate the expression 
level of CNTNAP2, though it is not required for axon guidance. The developmental role 
of FoxP2 in the CNS could explain how FoxP2 contributes to language development. 
This work also reveals an important mechanism involved in midline axon crossing: 5-HT 
regulates axon guidance via ephrinB2a. Moreover, alteration of 5-HT levels by hypoxia 
contributes to axon guidance defects. This offers a novel mechanism by which the 
developmental environment manipulates the neural circuits.  
Axon guidance is a critical process involved in brain wiring, and disruption of 
CNS connectivity may be associated with many neurological disorders. Consequently, 
uncovering the molecular mechanisms involved will facilitate progress toward 
understanding neurodevelopmental disorders and offer the possibility of improved 
therapeutic approaches.  
Axon guidance is not a process mediated by a single receptor induced by 
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intracellular signaling, but involves networks of multiple axon guidance molecules and 
receptors. Future studies will first address whether other axon guidance molecules, such 
as Slit-Robo and Netrin-DCC/Unc5, are regulated by 5-HT and/or are involved in axon 
guidance defects under hypoxic conditions. Additional work will analyze how the 
complicated network of multiple axon guidance molecules and their receptors functions 
to cause disruption of axon guidance following hypoxia. Further studies are also 
necessary to analyze the potential interaction between 5-HT and FoxP2 or CNTNAP2 in 
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